{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:00:03Z","timestamp":1790395203060,"version":"4.1.0"},"reference-count":602,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00393-019-0670-3","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T04:04:46Z","timestamp":1575000286000},"page":"3-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Fr\u00fchformen, Update 2019","Long version on the S3 guidelines for axial spondyloarthritis including Bechterew\u2019s disease and early forms, Update 2019"],"prefix":"10.1007","volume":"78","author":[{"name":"DGRh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Kiltz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DEGAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DWG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DVMB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DOG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DRG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DGMM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DGPMR\/DGRW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Physio Deutschland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DDG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DGOOC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DGIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DGOOC\/DGORh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DGNC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Chenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dreimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Heiligenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.\u2011G.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Klett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.\u2011F.","family":"Kreitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"M\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Oberschelp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rudwaleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. L.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stallmach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Winking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"issue":"9570","key":"670_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun\u00a0J, Sieper\u00a0J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390","journal-title":"Lancet"},{"issue":"6","key":"670_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et\u00a0al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et\u00a0al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68(6):770\u2013776","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean\u00a0LE et\u00a0al (2014) Global prevalence of ankylosing spondylitis. Rheumatol (oxford) 53(4):650\u2013657","journal-title":"Rheumatol (oxford)"},{"issue":"1","key":"670_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun\u00a0J et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58\u201367","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR6","first-page":"822","volume":"29","author":"R Almodovar","year":"2011","unstructured":"Almodovar\u00a0R et al (2011) Phenotypic differences between familial versus sporadic ankylosing spondylitis: a\u00a0cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheumatol 29(5):822\u2013827","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"670_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3899\/jrheum.111031","volume":"39","author":"HA Chen","year":"2012","unstructured":"Chen\u00a0HA et al (2012) Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J\u00a0Rheumatol 39(5):1013\u20131018","journal-title":"J Rheumatol"},{"issue":"10","key":"670_CR8","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s10067-017-3767-6","volume":"36","author":"F Jamalyaria","year":"2017","unstructured":"Jamalyaria\u00a0F et al (2017) Ethnicity and disease severity in ankylosing spondylitis a\u00a0cross-sectional analysis of three ethnic groups. Clin Rheumatol 36(10):2359\u20132364","journal-title":"Clin Rheumatol"},{"issue":"3","key":"670_CR9","first-page":"351","volume":"30","author":"TL Skare","year":"2012","unstructured":"Skare\u00a0TL et\u00a0al (2012) Effect of age at disease onset in the clinical profile of spondyloarthritis: a\u00a0study of 1424 Brazilian patients. Clin Exp Rheumatol 30(3):351\u2013357","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"670_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/ard.2008.091793","volume":"68","author":"R Landewe","year":"2009","unstructured":"Landewe\u00a0R et\u00a0al (2009) Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 68(6):863\u2013867","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/art.23523","volume":"59","author":"MM Ward","year":"2008","unstructured":"Ward\u00a0MM et\u00a0al (2008) Impact of ankylosing spondylitis on work and family life: comparisons with the US population. Arthritis Rheum 59(4):497\u2013503","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR12","first-page":"516","volume":"32","author":"H Dagfinrud","year":"2005","unstructured":"Dagfinrud\u00a0H et\u00a0al (2005) Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J\u00a0Rheumatol 32(3):516\u2013523","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR13","first-page":"721","volume":"32","author":"W Mau","year":"2005","unstructured":"Mau\u00a0W et\u00a0al (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J\u00a0Rheumatol 32(4):721\u2013728","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/ard.2009.116764","volume":"69","author":"A Boonen","year":"2010","unstructured":"Boonen\u00a0A et\u00a0al (2010) Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 69(6):1123\u20131128","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00007632-198003000-00016","volume":"5","author":"A Calin","year":"1980","unstructured":"Calin\u00a0A et\u00a0al (1980) The prevalence and nature of back pain in an industrial complex: a\u00a0questionnaire and radiographic and HLA analysis. Spine (phila Pa 1976) 5(2):201\u2013205","journal-title":"Spine (phila Pa 1976)"},{"issue":"2","key":"670_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller\u00a0E et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61\u201366","journal-title":"Rheumatol Int"},{"issue":"3","key":"670_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/art.1780270301","volume":"27","author":"SM van der Linden","year":"1984","unstructured":"van der Linden\u00a0SM et al (1984) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27(3):241\u2013249","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR18","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1136\/annrheumdis-2013-204867","volume":"74","author":"J Sorensen","year":"2015","unstructured":"Sorensen\u00a0J, Hetland\u00a0ML, D. all departments of rheumatology (2015) in, Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Ann Rheum Dis 74(3):e12","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13075-016-1027-9","volume":"18","author":"R Burgos-Varga","year":"2016","unstructured":"Burgos-Varga\u00a0R et al (2016) The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a\u00a0multinational, multicenter study. Arthritis Res Ther 18(1):132","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"670_CR20","first-page":"613","volume":"27","author":"A Zink","year":"2000","unstructured":"Zink\u00a0A et\u00a0al (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis\u2014results from the German rheumatological database. German Collaborative Arthritis Centers. J\u00a0Rheumatol 27(3):613\u2013622","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde\u00a0D et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/rheumatology\/ken506","volume":"48","author":"M Rojas-Vargas","year":"2009","unstructured":"Rojas-Vargas\u00a0M et al (2009) First signs and symptoms of spondyloarthritis\u2014data from an inception cohort with a\u00a0disease course of two years or less (REGISPONSER-Early). Rheumatol (oxford) 48(4):404\u2013409","journal-title":"Rheumatol (oxford)"},{"issue":"1","key":"670_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/rheumatology\/ket344","volume":"53","author":"L Hamilton","year":"2014","unstructured":"Hamilton\u00a0L et\u00a0al (2014) The prevalence of inflammatory back pain in a\u00a0UK primary care population. Rheumatol (oxford) 53(1):161\u2013164","journal-title":"Rheumatol (oxford)"},{"issue":"24","key":"670_CR24","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","volume":"237","author":"A Calin","year":"1977","unstructured":"Calin\u00a0A et\u00a0al (1977) Clinical history as a\u00a0screening test for ankylosing spondylitis. JAMA 237(24):2613\u20132614","journal-title":"JAMA"},{"issue":"2","key":"670_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit\u00a0M et\u00a0al (2006) Inflammatory back pain in ankylosing spondylitis: a\u00a0reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54(2):569\u2013578","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper\u00a0J et\u00a0al (2009) New criteria for inflammatory back pain in patients with chronic back pain: a\u00a0real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68(6):784\u2013788","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR27","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10067-014-2622-2","volume":"33","author":"D Solmaz","year":"2014","unstructured":"Solmaz\u00a0D et\u00a0al (2014) Performance of different criteria sets for inflammatory back pain in patients with axial spondyloarthritis with and without radiographic sacroiliitis. Clin Rheumatol 33(10):1475\u20131479","journal-title":"Clin Rheumatol"},{"issue":"1","key":"670_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jbspin.2017.01.010","volume":"85","author":"P Gazeau","year":"2018","unstructured":"Gazeau\u00a0P et\u00a0al (2018) Classification criteria versus physician\u2019s opinion for considering a\u00a0patient with inflammatory back pain as suffering from spondyloarthritis. Joint Bone Spine 85(1):85\u201391","journal-title":"Joint Bone Spine"},{"issue":"8","key":"670_CR29","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1136\/ard.2009.124206","volume":"69","author":"P Machado","year":"2010","unstructured":"Machado\u00a0P et\u00a0al (2010) Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis 69(8):1465\u20131470","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR30","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/ar3551","volume":"14","author":"U Weber","year":"2012","unstructured":"Weber\u00a0U et al (2012) Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a\u00a0cross-sectional study. Arthritis Res Ther 14(1):R3","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"670_CR31","first-page":"191","volume":"30","author":"J Payet","year":"2012","unstructured":"Payet\u00a0J et\u00a0al (2012) Prevalence and clinical characteristics of dactylitis in spondylarthritis: a\u00a0descriptive analysis of 275 patients. Clin Exp Rheumatol 30(2):191\u2013196","journal-title":"Clin Exp Rheumatol"},{"key":"670_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13075-015-0779-y","volume":"17","author":"V Navarro-Compan","year":"2015","unstructured":"Navarro-Compan\u00a0V et al (2015) Sponyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magnetic resonance imaging in patients with suspected axial spondyloarthritis: results from a\u00a0cross-sectional study in the ESPeranza Cohort. Arthritis Res Ther 17:265","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"670_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/acr.21878","volume":"65","author":"S Bethi","year":"2013","unstructured":"Bethi\u00a0S et\u00a0al (2013) Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res (hoboken) 65(4):607\u2013614","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"3","key":"670_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00296-015-3360-8","volume":"36","author":"SZ Aydin","year":"2016","unstructured":"Aydin\u00a0SZ et\u00a0al (2016) A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes. Rheumatol Int 36(3):397\u2013404","journal-title":"Rheumatol Int"},{"issue":"1","key":"670_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/RHU.0b013e318204a6f8","volume":"17","author":"S Ruta","year":"2011","unstructured":"Ruta\u00a0S et\u00a0al (2011) Prevalence of subclinical enthesopathy in patients with spondyloarthropathy: an ultrasound study. J\u00a0Clin Rheumatol 17(1):18\u201322","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"670_CR36","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/ard.2007.084244","volume":"68","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych\u00a0WP et\u00a0al (2009) Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 68(6):948\u2013953","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"L Heuft-Dorenbosch","year":"2003","unstructured":"Heuft-Dorenbosch\u00a0L et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127\u2013132","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR38","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/acr.22001","volume":"65","author":"A Tournadre","year":"2013","unstructured":"Tournadre\u00a0A et\u00a0al (2013) Differences between women and men with recent onset axial spondyloarthritis: results from the DESIR cohort. Arthritis Care Res (hoboken) 65(9):1482\u20131489","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"3","key":"670_CR39","first-page":"419","volume":"55","author":"C Webers","year":"2016","unstructured":"Webers\u00a0C et al (2016) Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. Rheumatol (oxford) 55(3):419\u2013428","journal-title":"Rheumatol (oxford)"},{"issue":"7","key":"670_CR40","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/annrheumdis-2012-202431","volume":"72","author":"IE van der Horst-Bruinsma","year":"2013","unstructured":"van der Horst-Bruinsma\u00a0IE et al (2013) Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies. Ann Rheum Dis 72(7):1221\u20131224","journal-title":"Ann Rheum Dis"},{"issue":"51","key":"670_CR41","doi-asserted-by":"publisher","first-page":"e5652","DOI":"10.1097\/MD.0000000000005652","volume":"95","author":"M Landi","year":"2016","unstructured":"Landi\u00a0M et\u00a0al (2016) Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort. Medicine (Baltimore) 95(51):e5652","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"670_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/rheumatology\/kem348","volume":"47","author":"PI Sidiropoulos","year":"2008","unstructured":"Sidiropoulos\u00a0PI et al (2008) Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a\u00a0broad panel of experts and practising rheumatologists. Rheumatol (oxford) 47(3):355\u2013361","journal-title":"Rheumatol (oxford)"},{"issue":"5","key":"670_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/ard.2003.011247","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit\u00a0M et\u00a0al (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63(5):535\u2013543","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR44","first-page":"1290","volume":"32","author":"K Karberg","year":"2005","unstructured":"Karberg\u00a0K et\u00a0al (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J\u00a0Rheumatol 32(7):1290\u20131298","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR45","doi-asserted-by":"publisher","first-page":"e0189569","DOI":"10.1371\/journal.pone.0189569","volume":"12","author":"D Wang","year":"2017","unstructured":"Wang\u00a0D et\u00a0al (2017) Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis. PLoS ONE 12(12):e189569","journal-title":"PLoS ONE"},{"issue":"2","key":"670_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/rheumatology\/kev332","volume":"55","author":"K Briot","year":"2016","unstructured":"Briot\u00a0K et\u00a0al (2016) Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort. Rheumatol (oxford) 55(2):335\u2013342","journal-title":"Rheumatol (oxford)"},{"issue":"11","key":"670_CR47","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G","volume":"42","author":"J Gratacos","year":"1999","unstructured":"Gratacos\u00a0J et\u00a0al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: a\u00a0followup study. Arthritis Rheum 42(11):2319\u20132324","journal-title":"Arthritis Rheum"},{"issue":"1","key":"670_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00198-014-2939-3","volume":"26","author":"D Prieto-Alhambra","year":"2015","unstructured":"Prieto-Alhambra\u00a0D et al (2015) Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a\u00a0nationwide case-control study. Osteoporos Int 26(1):85\u201391","journal-title":"Osteoporos Int"},{"issue":"8","key":"670_CR49","first-page":"1637","volume":"33","author":"JB Jun","year":"2006","unstructured":"Jun\u00a0JB et al (2006) Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a\u00a0cross-sectional study. J\u00a0Rheumatol 33(8):1637\u20131641","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR50","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1136\/ard.2008.100503","volume":"68","author":"D Vosse","year":"2009","unstructured":"Vosse\u00a0D et al (2009) Ankylosing spondylitis and the risk of fracture: results from a\u00a0large primary care-based nested case-control study. Ann Rheum Dis 68(12):1839\u20131842","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13075-017-1480-0","volume":"19","author":"A Deminger","year":"2017","unstructured":"Deminger\u00a0A et al (2017) Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a\u00a05-year prospective study. Arthritis Res Ther 19(1):273","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"670_CR52","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3899\/jrheum.100851","volume":"38","author":"N Montala","year":"2011","unstructured":"Montala\u00a0N et\u00a0al (2011) Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J\u00a0Rheumatol 38(5):893\u2013897","journal-title":"J Rheumatol"},{"issue":"2","key":"670_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00586-008-0764-0","volume":"18","author":"LA Westerveld","year":"2009","unstructured":"Westerveld\u00a0LA, Verlaan\u00a0JJ, Oner\u00a0FC (2009) Spinal fractures in patients with ankylosing spinal disorders: a\u00a0systematic review of the literature on treatment, neurological status and complications. Eur Spine\u00a0J 18(2):145\u2013156","journal-title":"Eur Spine J"},{"issue":"2","key":"670_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/RHU.0000000000000216","volume":"21","author":"N Dursun","year":"2015","unstructured":"Dursun\u00a0N et\u00a0al (2015) Risk of falls in patients with ankylosing spondylitis. J\u00a0Clin Rheumatol 21(2):76\u201380","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"670_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13075-017-1453-3","volume":"19","author":"M Protopopov","year":"2017","unstructured":"Protopopov\u00a0M et\u00a0al (2017) Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Res Ther 19(1):240","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"670_CR56","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/rheumatology\/keh169","volume":"43","author":"KL Haywood","year":"2004","unstructured":"Haywood\u00a0KL et\u00a0al (2004) Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatol (oxford) 43(6):750\u2013757","journal-title":"Rheumatol (oxford)"},{"issue":"7","key":"670_CR57","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/ard.2004.029728","volume":"64","author":"A Wanders","year":"2005","unstructured":"Wanders\u00a0A et\u00a0al (2005) Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a\u00a0proxy for radiographic evaluation? Ann Rheum Dis 64(7):988\u2013994","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR58","first-page":"1779","volume":"31","author":"L Heuft-Dorenbosch","year":"2004","unstructured":"Heuft-Dorenbosch\u00a0L et al (2004) Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. J\u00a0Rheumatol 31(9):1779\u20131784","journal-title":"J Rheumatol"},{"issue":"4 Suppl","key":"670_CR59","doi-asserted-by":"publisher","first-page":"142S","DOI":"10.1016\/S0197-2456(05)80019-4","volume":"12","author":"RA Deyo","year":"1991","unstructured":"Deyo\u00a0RA, Diehr\u00a0P, Patrick\u00a0DL (1991) Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 12(4 Suppl):142S\u2013158S","journal-title":"Control Clin Trials"},{"issue":"1","key":"670_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/rheumatology\/30.1.29","volume":"30","author":"KD Pile","year":"1991","unstructured":"Pile\u00a0KD et\u00a0al (1991) Clinical assessment of ankylosing spondylitis: a\u00a0study of observer variation in spinal measurements. Br J Rheumatol 30(1):29\u201334","journal-title":"Br J Rheumatol"},{"issue":"8","key":"670_CR61","first-page":"1733","volume":"34","author":"DD Gladman","year":"2007","unstructured":"Gladman\u00a0DD et\u00a0al (2007) International spondyloarthritis interobserver reliability exercise\u2014the INSPIRE study: I. Assessment of spinal measures. J\u00a0Rheumatol 34(8):1733\u20131739","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR62","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/rheumatology\/34.8.767","volume":"34","author":"LG Kennedy","year":"1995","unstructured":"Kennedy\u00a0LG et\u00a0al (1995) Ankylosing spondylitis: the correlation between a\u00a0new metrology score and radiology. Br J Rheumatol 34(8):767\u2013770","journal-title":"Br J Rheumatol"},{"issue":"12","key":"670_CR63","first-page":"2463","volume":"34","author":"V Chandran","year":"2007","unstructured":"Chandran\u00a0V et\u00a0al (2007) Relationship between spinal mobility and radiographic damage in ankylosing spondylitis and psoriatic spondylitis: a\u00a0comparative analysis. J\u00a0Rheumatol 34(12):2463\u20132465","journal-title":"J Rheumatol"},{"issue":"1","key":"670_CR64","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00586-013-2929-8","volume":"23","author":"JK Shin","year":"2014","unstructured":"Shin\u00a0JK et\u00a0al (2014) Correlation between clinical outcome and spinopelvic parameters in ankylosing spondylitis. Eur Spine\u00a0J 23(1):242\u2013247","journal-title":"Eur Spine J"},{"issue":"9","key":"670_CR65","first-page":"1694","volume":"21","author":"TR Jenkinson","year":"1994","unstructured":"Jenkinson\u00a0TR et\u00a0al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J\u00a0Rheumatol 21(9):1694\u20131698","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR66","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin\u00a0A et\u00a0al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J\u00a0Rheumatol 21(12):2281\u20132285","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR67","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett\u00a0S et\u00a0al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J\u00a0Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR68","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s003930050174","volume":"58","author":"J Ruof","year":"1999","unstructured":"Ruof\u00a0J, Sangha\u00a0O, Stucki\u00a0G (1999) Evaluation of a\u00a0German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI). Z\u00a0Rheumatol 58(4):218\u2013225","journal-title":"Z Rheumatol"},{"issue":"6","key":"670_CR69","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3899\/jrheum.080831","volume":"36","author":"A Boonen","year":"2009","unstructured":"Boonen\u00a0A et\u00a0al (2009) Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J\u00a0Rheumatol 36(6):1249\u20131255","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR70","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/art.21444","volume":"53","author":"MM Ward","year":"2005","unstructured":"Ward\u00a0MM et al (2005) Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 53(5):710\u2013717","journal-title":"Arthritis Rheum"},{"issue":"7","key":"670_CR71","first-page":"946","volume":"17","author":"LH Daltroy","year":"1990","unstructured":"Daltroy\u00a0LH et\u00a0al (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J\u00a0Rheumatol 17(7):946\u2013950","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR72","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/ard.2006.064543","volume":"66","author":"B Vander Cruyssen","year":"2007","unstructured":"Vander Cruyssen\u00a0B et al (2007) The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis 66(8):1072\u20131077","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR73","first-page":"2283","volume":"28","author":"S Brophy","year":"2001","unstructured":"Brophy\u00a0S, Calin\u00a0A (2001) Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J\u00a0Rheumatol 28(10):2283\u20132288","journal-title":"J Rheumatol"},{"issue":"3","key":"670_CR74","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et\u00a0al (2009) The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 60(3):717\u2013727","journal-title":"Arthritis Rheum"},{"issue":"9","key":"670_CR75","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/acr.21688","volume":"64","author":"U Kiltz","year":"2012","unstructured":"Kiltz\u00a0U et al (2012) Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (hoboken) 64(9):1415\u20131422","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"1","key":"670_CR76","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk\u00a0C et al (2015) Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a\u00a0systematic review and meta-analysis. Ann Rheum Dis 74(1):65\u201373","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR77","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/kem084","volume":"46","author":"E Collantes","year":"2007","unstructured":"Collantes\u00a0E et\u00a0al (2007) Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatol (oxford) 46(8):1309\u20131315","journal-title":"Rheumatol (oxford)"},{"issue":"4","key":"670_CR78","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/acr.20408","volume":"63","author":"A Bremander","year":"2011","unstructured":"Bremander\u00a0A et al (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (hoboken) 63(4):550\u2013556","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"12","key":"670_CR79","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/ard.2002.004861","volume":"62","author":"AM Chorus","year":"2003","unstructured":"Chorus\u00a0AM et\u00a0al (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62(12):1178\u20131184","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR80","first-page":"484","volume":"31","author":"PD Sampaio-Barros","year":"2013","unstructured":"Sampaio-Barros\u00a0PD et al (2013) An analysis of 372 patients with anterior uveitis in a\u00a0large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group. Clin Exp Rheumatol 31(4):484\u2013489","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"670_CR81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/acr.21616","volume":"64","author":"F Canoui-Poitrine","year":"2012","unstructured":"Canoui-Poitrine\u00a0F et al (2012) Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey. Arthritis Care Res (hoboken) 64(6):919\u2013924","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"7","key":"670_CR82","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/ard.2007.075754","volume":"67","author":"N Zeboulon","year":"2008","unstructured":"Zeboulon\u00a0N, Dougados\u00a0M, Gossec\u00a0L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a\u00a0systematic literature review. Ann Rheum Dis 67(7):955\u2013959","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR83","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","volume":"54","author":"I Essers","year":"2015","unstructured":"Essers\u00a0I et al (2015) Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS. Rheumatol (oxford) 54(4):633\u2013640","journal-title":"Rheumatol (oxford)"},{"issue":"1","key":"670_CR84","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/art.38873","volume":"67","author":"PC Robinson","year":"2015","unstructured":"Robinson\u00a0PC et\u00a0al (2015) Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol 67(1):140\u2013151","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"670_CR85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0889-857X(21)00714-6","volume":"18","author":"JT Rosenbaum","year":"1992","unstructured":"Rosenbaum\u00a0JT (1992) Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am 18(1):143\u2013151","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"670_CR86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/09273941003597268","volume":"18","author":"M Accorinti","year":"2010","unstructured":"Accorinti\u00a0M et al (2010) Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Ocul Immunol Inflamm 18(2):91\u201396","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"670_CR87","first-page":"1277","volume":"30","author":"S Munoz-Fernandez","year":"2003","unstructured":"Munoz-Fernandez\u00a0S et al (2003) Sulfasalazine reduces the number of flares of acute anterior uveitis over a\u00a0one-year period. J\u00a0Rheumatol 30(6):1277\u20131279","journal-title":"J Rheumatol"},{"issue":"Pt 3A","key":"670_CR88","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/eye.2000.84","volume":"14","author":"JM Benitez-Del-Castillo","year":"2000","unstructured":"Benitez-Del-Castillo\u00a0JM et al (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye (Lond) 14(Pt 3A):340\u2013343","journal-title":"Eye (Lond)"},{"issue":"10050","key":"670_CR89","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen\u00a0QD et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a\u00a0multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388(10050):1183\u20131192","journal-title":"Lancet"},{"issue":"8","key":"670_CR90","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/art.21197","volume":"52","author":"J Braun","year":"2005","unstructured":"Braun\u00a0J et al (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52(8):2447\u20132451","journal-title":"Arthritis Rheum"},{"issue":"1","key":"670_CR91","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/ard.2008.103192","volume":"69","author":"J Sieper","year":"2010","unstructured":"Sieper\u00a0J et\u00a0al (2010) Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials. Ann Rheum Dis 69(1):226\u2013229","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR92","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3111\/13696998.2012.692341","volume":"15","author":"X Gao","year":"2012","unstructured":"Gao\u00a0X et al (2012) Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents. J\u00a0Med Econ 15(6):1054\u20131063","journal-title":"J Med Econ"},{"issue":"9","key":"670_CR93","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210931","volume":"76","author":"E Lie","year":"2017","unstructured":"Lie\u00a0E et\u00a0al (2017) Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Ann Rheum Dis 76(9):1515\u20131521","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"670_CR94","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1185\/03007995.2014.969368","volume":"30","author":"D Wendling","year":"2014","unstructured":"Wendling\u00a0D et al (2014) Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a\u00a0large US claims database. Curr Med Res Opin 30(12):2515\u20132521","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"670_CR95","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a\u00a0prospective open-label study. Ann Rheum Dis 68(5):696\u2013701","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR96","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","volume":"120","author":"AD Dick","year":"2013","unstructured":"Dick\u00a0AD et\u00a0al (2013) Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology 120(4):777\u2013787","journal-title":"Ophthalmology"},{"issue":"5","key":"670_CR97","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","volume":"122","author":"E Letko","year":"2015","unstructured":"Letko\u00a0E et al (2015) Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy. Ophthalmology 122(5):939\u2013948","journal-title":"Ophthalmology"},{"issue":"1","key":"670_CR98","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0950-3579(96)80010-0","volume":"10","author":"H Mielants","year":"1996","unstructured":"Mielants\u00a0H et\u00a0al (1996) Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillieres Clin Rheumatol 10(1):147\u2013164","journal-title":"Baillieres Clin Rheumatol"},{"issue":"12","key":"670_CR99","first-page":"2279","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants\u00a0H et\u00a0al (1995) The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J\u00a0Rheumatol 22(12):2279\u20132284","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR100","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.dld.2009.01.013","volume":"41","author":"R D\u2019Inca","year":"2009","unstructured":"D\u2019Inca\u00a0R et\u00a0al (2009) Articular manifestations in inflammatory bowel disease patients: a\u00a0prospective study. Dig Liver Dis 41(8):565\u2013569","journal-title":"Dig Liver Dis"},{"issue":"1","key":"670_CR101","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1440-1746.2007.05108.x","volume":"23","author":"H Peeters","year":"2008","unstructured":"Peeters\u00a0H et\u00a0al (2008) Clinical and genetic factors associated with sacroiliitis in Crohn\u2019s disease. J\u00a0Gastroenterol Hepatol 23(1):132\u2013137","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"670_CR102","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka\u00a0SR et\u00a0al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106(1):110\u2013119","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"670_CR103","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","volume":"101","author":"Y El Miedany","year":"2006","unstructured":"El Miedany\u00a0Y et al (2006) The gastrointestinal safety and effect on disease activity of etoricoxib, a\u00a0selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol 101(2):311\u2013317","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"670_CR104","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1055\/s-2008-1027796","volume":"46","author":"JC Hoffmann","year":"2008","unstructured":"Hoffmann\u00a0JC et\u00a0al (2008) Clinical practice guideline on diagnosis and treatment of Crohn\u2019s disease. Z\u00a0Gastroenterol 46(9):1094\u20131146","journal-title":"Z Gastroenterol"},{"issue":"4","key":"670_CR105","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/art.22669","volume":"57","author":"J Braun","year":"2007","unstructured":"Braun\u00a0J et al (2007) Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 57(4):639\u2013647","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR106","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jbspin.2011.10.001","volume":"79","author":"E Toussirot","year":"2012","unstructured":"Toussirot\u00a0E et al (2012) Development of inflammatory bowel disease during anti-TNF-alpha therapy for inflammatory rheumatic disease. A\u00a0nationwide series. Joint Bone Spine 79(5):457\u2013463","journal-title":"Joint Bone Spine"},{"issue":"12","key":"670_CR107","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber\u00a0W et al (2012) Secukinumab, a\u00a0human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a\u00a0randomised, double-blind placebo-controlled trial. Gut 61(12):1693\u20131700","journal-title":"Gut"},{"issue":"2","key":"670_CR108","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0002-9343(82)90177-2","volume":"73","author":"L Bergfeldt","year":"1982","unstructured":"Bergfeldt\u00a0L et al (1982) Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men. Am J Med 73(2):187\u2013191","journal-title":"Am J Med"},{"issue":"6","key":"670_CR109","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/ard.51.6.705","volume":"51","author":"TW O\u2019Neill","year":"1992","unstructured":"O\u2019Neill\u00a0TW, Bresnihan\u00a0B (1992) The heart in ankylosing spondylitis. Ann Rheum Dis 51(6):705\u2013706","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR110","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/annrheumdis-2017-212189","volume":"77","author":"K Bengtsson","year":"2018","unstructured":"Bengtsson\u00a0K et al (2018) Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a\u00a0register-based study from Sweden. Ann Rheum Dis 77(4):541\u2013548","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR111","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10067-006-0286-2","volume":"26","author":"PD Sampaio-Barros","year":"2007","unstructured":"Sampaio-Barros\u00a0PD et al (2007) Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol 26(2):225\u2013230","journal-title":"Clin Rheumatol"},{"issue":"2","key":"670_CR112","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10067-003-0845-8","volume":"23","author":"A El Maghraoui","year":"2004","unstructured":"El Maghraoui\u00a0A et al (2004) Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol 23(2):123\u2013128","journal-title":"Clin Rheumatol"},{"issue":"4","key":"670_CR113","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.rti.0000139405.51472.7a","volume":"19","author":"AS Souza Jr.","year":"2004","unstructured":"Souza\u00a0AS Jr. et al (2004) Pulmonary abnormalities in ankylosing spondylitis: inspiratory and expiratory high-resolution CT findings in 17 patients. J\u00a0Thorac Imaging 19(4):259\u2013263","journal-title":"J Thorac Imaging"},{"issue":"5","key":"670_CR114","first-page":"912","volume":"24","author":"J Gratacos","year":"1997","unstructured":"Gratacos\u00a0J et\u00a0al (1997) Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J\u00a0Rheumatol 24(5):912\u2013915","journal-title":"J Rheumatol"},{"issue":"7","key":"670_CR115","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00296-012-2624-9","volume":"33","author":"SH Lee","year":"2013","unstructured":"Lee\u00a0SH et al (2013) Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker. Rheumatol Int 33(7):1689\u20131692","journal-title":"Rheumatol Int"},{"issue":"11","key":"670_CR116","doi-asserted-by":"publisher","first-page":"e113602","DOI":"10.1371\/journal.pone.0113602","volume":"9","author":"AK Jakobsen","year":"2014","unstructured":"Jakobsen\u00a0AK et al (2014) Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects. PLoS ONE 9(11):e113602","journal-title":"PLoS ONE"},{"issue":"6","key":"670_CR117","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","volume":"75","author":"A Molto","year":"2016","unstructured":"Molto\u00a0A et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016\u20131023","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR118","first-page":"396","volume":"34","author":"I Hmamouchi","year":"2016","unstructured":"Hmamouchi\u00a0I et\u00a0al (2016) Vitamin D, disease activity and comorbidities in early spondyloarthritis. Clin Exp Rheumatol 34(3):396\u2013403","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"670_CR119","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13075-014-0418-z","volume":"16","author":"JJ Meesters","year":"2014","unstructured":"Meesters\u00a0JJ et al (2014) The risk for depression in patients with ankylosing spondylitis: a\u00a0population-based cohort study. Arthritis Res Ther 16(5):418","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"670_CR120","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1186\/ar4054","volume":"14","author":"Y Li","year":"2012","unstructured":"Li\u00a0Y et al (2012) Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a\u00a0case-control study. Arthritis Res Ther 14(5):R215","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"670_CR121","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/1756-185X.12683","volume":"18","author":"U Dhakad","year":"2015","unstructured":"Dhakad\u00a0U et\u00a0al (2015) Sexual dysfunctions and lower urinary tract symptoms in ankylosing spondylitis. Int J Rheum Dis 18(8):866\u2013872","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"670_CR122","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3899\/jrheum.170630","volume":"45","author":"JD Dau","year":"2018","unstructured":"Dau\u00a0JD et\u00a0al (2018) Opioid analgesic use in patients with Ankylosing Spondylitis: an analysis of the prospective study of outcomes in an Ankylosing Spondylitis cohort. J\u00a0Rheumatol 45(2):188\u2013194","journal-title":"J Rheumatol"},{"issue":"2","key":"670_CR123","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3899\/jrheum.150648","volume":"43","author":"F Maas","year":"2016","unstructured":"Maas\u00a0F et\u00a0al (2016) Obesity is common in axial Spondyloarthritis and is associated with poor clinical outcome. J\u00a0Rheumatol 43(2):383\u2013387","journal-title":"J Rheumatol"},{"issue":"9","key":"670_CR124","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kex318","volume":"57","author":"X Baraliakos","year":"2018","unstructured":"Baraliakos\u00a0X et\u00a0al (2018) Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatol (oxford) 57(9):1541\u20131547","journal-title":"Rheumatol (oxford)"},{"issue":"4","key":"670_CR125","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"77","author":"A Molto","year":"2018","unstructured":"Molto\u00a0A et\u00a0al (2018) Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers\u2019 effectiveness in axial spondyloarthritis: results of a\u00a0prospective, multicentre study. Ann Rheum Dis 77(4):533\u2013540","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR126","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/art.40185","volume":"69","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane\u00a0GJ et al (2017) Co-occurrence and characteristics of patients with axial Spondyloarthritis who meet criteria for Fibromyalgia: results from a\u00a0UK national register. Arthritis Rheumatol 69(11):2144\u20132150","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"670_CR127","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters\u00a0MJ et\u00a0al (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34(3):585\u2013592","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"670_CR128","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon\u00a0NN et al (2015) Patients with Ankylosing Spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163(6):409\u2013416","journal-title":"Ann Intern Med"},{"issue":"4","key":"670_CR129","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/BOR.0b013e328133f58e","volume":"19","author":"S Heeneman","year":"2007","unstructured":"Heeneman\u00a0S, Daemen\u00a0MJ (2007) Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 19(4):358\u2013362","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"670_CR130","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3899\/jrheum.150316","volume":"42","author":"A Arida","year":"2015","unstructured":"Arida\u00a0A et\u00a0al (2015) Subclinical atherosclerosis is not accelerated in patients with Ankylosing Spondylitis with low disease activity: new data and metaanalysis of published studies. J\u00a0Rheumatol 42(11):2098\u20132105","journal-title":"J Rheumatol"},{"issue":"2","key":"670_CR131","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/rheumatology\/keu337","volume":"54","author":"Y Chen","year":"2015","unstructured":"Chen\u00a0Y et\u00a0al (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatol (oxford) 54(2):292\u2013301","journal-title":"Rheumatol (oxford)"},{"issue":"5","key":"670_CR132","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jbspin.2007.11.007","volume":"75","author":"JY Choe","year":"2008","unstructured":"Choe\u00a0JY et al (2008) No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine 75(5):548\u2013553","journal-title":"Joint Bone Spine"},{"issue":"6","key":"670_CR133","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","volume":"88","author":"C Gonzalez-Juanatey","year":"2009","unstructured":"Gonzalez-Juanatey\u00a0C et al (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88(6):358\u2013365","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"670_CR134","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.090667","volume":"37","author":"MJ Peters","year":"2010","unstructured":"Peters\u00a0MJ et\u00a0al (2010) Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J\u00a0Rheumatol 37(1):161\u2013166","journal-title":"J Rheumatol"},{"issue":"1","key":"670_CR135","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson\u00a0K et al (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19(1):102","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"670_CR136","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/ard.2009.110593","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters\u00a0MJ et\u00a0al (2010) Ankylosing spondylitis: a\u00a0risk factor for myocardial infarction? Ann Rheum Dis 69(3):579\u2013581","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR137","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/acr.20364","volume":"63","author":"S Mathieu","year":"2011","unstructured":"Mathieu\u00a0S et al (2011) Cardiovascular profile in ankylosing spondylitis: a\u00a0systematic review and meta-analysis. Arthritis Care Res (hoboken) 63(4):557\u2013563","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"11","key":"670_CR138","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/ard.2005.050443","volume":"65","author":"VP van Halm","year":"2006","unstructured":"van Halm\u00a0VP et\u00a0al (2006) Increased disease activity is associated with a\u00a0deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65(11):1473\u20131477","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR139","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3899\/jrheum.141018","volume":"42","author":"IJ Berg","year":"2015","unstructured":"Berg\u00a0IJ et al (2015) Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a\u00a0cross-sectional study. J\u00a0Rheumatol 42(4):645\u2013653","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR140","first-page":"2440","volume":"33","author":"E Spanakis","year":"2006","unstructured":"Spanakis\u00a0E et\u00a0al (2006) Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J\u00a0Rheumatol 33(12):2440\u20132446","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR141","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.24492","volume":"60","author":"IC van Eijk","year":"2009","unstructured":"van Eijk\u00a0IC et al (2009) Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a\u00a0prospective cohort study in ankylosing spondylitis. Arthritis Rheum 60(5):1324\u20131330","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR142","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/ard.2007.086777","volume":"68","author":"IC van Eijk","year":"2009","unstructured":"van Eijk\u00a0IC et\u00a0al (2009) Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis 68(3):362\u2013366","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR143","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters\u00a0MJ et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325\u2013331","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR144","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3109\/14397595.2014.906049","volume":"24","author":"WA Bianchi","year":"2014","unstructured":"Bianchi\u00a0WA et\u00a0al (2014) Assessment of fatigue in a\u00a0large series of 1492 Brazilian patients with Spondyloarthritis. Mod Rheumatol 24(6):980\u2013984","journal-title":"Mod Rheumatol"},{"issue":"6","key":"670_CR145","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3109\/s10165-012-0800-0","volume":"23","author":"BM Alkan","year":"2013","unstructured":"Alkan\u00a0BM et al (2013) Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis. Mod Rheumatol 23(6):1101\u20131107","journal-title":"Mod Rheumatol"},{"issue":"1","key":"670_CR146","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/art1.10179","volume":"47","author":"A van Tubergen","year":"2002","unstructured":"van Tubergen\u00a0A et\u00a0al (2002) Assessment of fatigue in patients with ankylosing spondylitis: a\u00a0psychometric analysis. Arthritis Rheum 47(1):8\u201316","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR147","first-page":"487","volume":"23","author":"SD Jones","year":"1996","unstructured":"Jones\u00a0SD et\u00a0al (1996) Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J\u00a0Rheumatol 23(3):487\u2013490","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR148","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3899\/jrheum.150463","volume":"42","author":"M Bedaiwi","year":"2015","unstructured":"Bedaiwi\u00a0M et\u00a0al (2015) Fatigue in Ankylosing Spondylitis and Nonradiographic axial Spondyloarthritis: analysis from a\u00a0longitudinal observation cohort. J\u00a0Rheumatol 42(12):2354\u20132360","journal-title":"J Rheumatol"},{"issue":"1","key":"670_CR149","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/art.20910","volume":"53","author":"H Dagfinrud","year":"2005","unstructured":"Dagfinrud\u00a0H et al (2005) Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 53(1):5\u201311","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR150","first-page":"864","volume":"31","author":"K Chauffier","year":"2013","unstructured":"Chauffier\u00a0K et al (2013) Fatigue in spondyloarthritis: a\u00a0marker of disease activity. A cross-sectional study of 266 patients. Clin Exp Rheumatol 31(6):864\u2013870","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"670_CR151","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jbspin.2015.07.012","volume":"83","author":"L Gossec","year":"2016","unstructured":"Gossec\u00a0L et\u00a0al (2016) Fatigue in early axial spondyloarthritis. Results from the French DESIR cohort. Joint Bone Spine 83(4):427\u2013431","journal-title":"Joint Bone Spine"},{"issue":"4","key":"670_CR152","doi-asserted-by":"publisher","first-page":"R124","DOI":"10.1186\/ar2790","volume":"11","author":"DM van der Heijde","year":"2009","unstructured":"van der Heijde\u00a0DM et al (2009) Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis. Arthritis Res Ther 11(4):R124","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"670_CR153","first-page":"1346","volume":"35","author":"DA Revicki","year":"2008","unstructured":"Revicki\u00a0DA et al (2008) Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). J\u00a0Rheumatol 35(7):1346\u20131353","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR154","first-page":"571","volume":"35","author":"S Espahbodi","year":"2017","unstructured":"Espahbodi\u00a0S et al (2017) Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a\u00a0cross-sectional UK study. Clin Exp Rheumatol 35(4):571\u2013578","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Suppl 55","key":"670_CR155","first-page":"S127","volume":"27","author":"J Zochling","year":"2009","unstructured":"Zochling\u00a0J, Braun\u00a0J (2009) Mortality in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 27(4 Suppl 55):S127\u201330","journal-title":"Clin Exp Rheumatol"},{"issue":"5474","key":"670_CR156","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/bmj.2.5474.1327","volume":"2","author":"WM Brown","year":"1965","unstructured":"Brown\u00a0WM, Doll\u00a0R (1965) Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med\u00a0J 2(5474):1327\u20131332","journal-title":"Br Med J"},{"issue":"8","key":"670_CR157","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","volume":"75","author":"S Exarchou","year":"2016","unstructured":"Exarchou\u00a0S et al (2016) Mortality in ankylosing spondylitis: results from a\u00a0nationwide population-based study. Ann Rheum Dis 75(8):1466\u20131472","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR158","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1136\/annrheumdis-2017-211253","volume":"76","author":"A Oza","year":"2017","unstructured":"Oza\u00a0A et al (2017) Survival benefit of statin use in ankylosing spondylitis: a\u00a0general population-based cohort study. Ann Rheum Dis 76(10):1737\u20131742","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR159","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland\u00a0G, Gran\u00a0JT, Nossent\u00a0JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70(11):1921\u20131925","journal-title":"Ann Rheum Dis"},{"key":"670_CR160","series-title":"Gesundheitsberichterstattung des Bundes","volume-title":"Entz\u00fcndlich rheumatische Erkrankungen","author":"A Zink","year":"2010","unstructured":"Zink\u00a0A, Minden\u00a0K (2010) Entz\u00fcndlich rheumatische Erkrankungen. Gesundheitsberichterstattung des Bundes, Bd. 49. R.-K.I., Berlin"},{"issue":"2","key":"670_CR161","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/acr.22934","volume":"69","author":"KD Wysham","year":"2017","unstructured":"Wysham\u00a0KD et\u00a0al (2017) Cervical spinal fracture and other diagnoses associated with mortality in hospitalized Ankylosing Spondylitis patients. Arthritis Care Res (hoboken) 69(2):271\u2013277","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"6","key":"670_CR162","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/rheumatology\/ken060","volume":"47","author":"RR Wick","year":"2008","unstructured":"Wick\u00a0RR et al (2008) Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224. Rheumatol (oxford) 47(6):855\u2013859","journal-title":"Rheumatol (oxford)"},{"issue":"1","key":"670_CR163","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit\u00a0M et\u00a0al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR164","first-page":"85","volume":"57","author":"B Amor","year":"1990","unstructured":"Amor\u00a0B, Dougados\u00a0M, Mijiyawa\u00a0M (1990) Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 57(2):85\u201389","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"10","key":"670_CR165","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados\u00a0M et\u00a0al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218\u20131227","journal-title":"Arthritis Rheum"},{"issue":"51\u201352","key":"670_CR166","first-page":"883","volume":"114","author":"JF Chenot","year":"2017","unstructured":"Chenot\u00a0JF et al (2017) Non-specific low back pain. Dtsch Arztebl Int 114(51\u201352):883\u2013890","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"670_CR167","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/ard.2011.153064","volume":"71","author":"SZ Aydin","year":"2012","unstructured":"Aydin\u00a0SZ et\u00a0al (2012) Validation of the ASAS criteria and definition of a\u00a0positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis 71(1):56\u201360","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR168","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/annrheumdis-2015-208730","volume":"75","author":"A Sepriano","year":"2016","unstructured":"Sepriano\u00a0A et al (2016) Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a\u00a0final analysis. Ann Rheum Dis 75(6):1034\u20131042","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR169","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/acr.22016","volume":"65","author":"A Molto","year":"2013","unstructured":"Molto\u00a0A et al (2013) Performances of the Assessment of SpondyloArthritis International Society axial spondyloarthritis criteria for diagnostic and classification purposes in patients visiting a\u00a0rheumatologist because of chronic back pain: results from a\u00a0multicenter, cross-sectional study. Arthritis Care Res (hoboken) 65(9):1472\u20131481","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"4","key":"670_CR170","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/annrheumdis-2013-204262","volume":"74","author":"A Molto","year":"2014","unstructured":"Molto\u00a0A et\u00a0al (2014) Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort. Ann Rheum Dis 74(4):746\u2013751","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR171","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit\u00a0M et\u00a0al (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52(4):1000\u20131008. https:\/\/doi.org\/10.1002\/art.20990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR172","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/annrheumdis-2016-210119","volume":"76","author":"Z Ez-Zaitouni","year":"2017","unstructured":"Ez-Zaitouni\u00a0Z et al (2017) Presence of multiple spondyloarthritis (SpA) features is important but not sufficient for a\u00a0diagnosis of axial spondyloarthritis: data from the SPondyloArthritis Caught Early (SPACE) cohort. Ann Rheum Dis 76(6):1086\u20131092","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR173","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/acr.22883","volume":"68","author":"PA Bakker","year":"2016","unstructured":"Bakker\u00a0PA et al (2016) Are additional tests needed to rule out axial Spondyloarthritis in patients ages 16\u201345 years with short-duration chronic back pain and maximally one Spondyloarthritis feature? Arthritis Care Res (hoboken) 68(11):1726\u20131730","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"6","key":"670_CR174","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/acr.23017","volume":"69","author":"BE Joven","year":"2017","unstructured":"Joven\u00a0BE et\u00a0al (2017) Diagnostic value and validity of early Spondyloarthritis features: results from a\u00a0national Spanish cohort. Arthritis Care Res (hoboken) 69(6):938\u2013942","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"4","key":"670_CR175","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden\u00a0S, Valkenburg\u00a0HA, Cats\u00a0A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"1","key":"670_CR176","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s13075-015-0897-6","volume":"17","author":"JK Wallman","year":"2015","unstructured":"Wallman\u00a0JK et al (2015) Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients\u2014baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice. Arthritis Res Ther 17(1):378","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"670_CR177","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/1756-185X.12579","volume":"18","author":"AN Malaviya","year":"2015","unstructured":"Malaviya\u00a0AN et al (2015) Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a\u00a0single rheumatology clinic in New Delhi. Int J Rheum Dis 18(7):736\u2013741","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"670_CR178","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3899\/jrheum.160958","volume":"44","author":"B Glintborg","year":"2017","unstructured":"Glintborg\u00a0B et al (2017) Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry. J\u00a0Rheumatol 44(1):59\u201369","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR179","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/ard.2004.028753","volume":"64","author":"J Sieper","year":"2005","unstructured":"Sieper\u00a0J, Rudwaleit\u00a0M (2005) Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis 64(5):659\u2013663","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR180","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/ard.2006.053918","volume":"66","author":"L Heuft-Dorenbosch","year":"2007","unstructured":"Heuft-Dorenbosch\u00a0L et al (2007) Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 66(1):92\u201398","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR181","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/rheumatology\/kew228","volume":"55","author":"LE Dean","year":"2016","unstructured":"Dean\u00a0LE, Macfarlane\u00a0GJ, Jones\u00a0GT (2016) Differences in the prevalence of ankylosing spondylitis in primary and secondary care: only one-third of patients are managed in rheumatology. Rheumatol (oxford) 55(10):1820\u20131825","journal-title":"Rheumatol (oxford)"},{"issue":"7","key":"670_CR182","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s10067-016-3231-z","volume":"35","author":"A Deodhar","year":"2016","unstructured":"Deodhar\u00a0A et\u00a0al (2016) Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay. Clin Rheumatol 35(7):1769\u20131776","journal-title":"Clin Rheumatol"},{"issue":"11","key":"670_CR183","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/rheumatology\/34.11.1074","volume":"34","author":"MR Underwood","year":"1995","unstructured":"Underwood\u00a0MR, Dawes\u00a0P (1995) Inflammatory back pain in primary care. Br J Rheumatol 34(11):1074\u20131077","journal-title":"Br J Rheumatol"},{"issue":"8","key":"670_CR184","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/acr.21994","volume":"65","author":"V Strand","year":"2013","unstructured":"Strand\u00a0V et\u00a0al (2013) Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res (hoboken) 65(8):1299\u20131306","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"6","key":"670_CR185","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/03009740902978085","volume":"38","author":"ZT Liao","year":"2009","unstructured":"Liao\u00a0ZT et\u00a0al (2009) An epidemiological survey of low back pain and axial spondyloarthritis in a\u00a0Chinese Han population. Scand J Rheumatol 38(6):455\u2013459","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"670_CR186","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/annrheumdis-2012-201403","volume":"72","author":"MH Weisman","year":"2013","unstructured":"Weisman\u00a0MH, Witter\u00a0JP, Reveille\u00a0JD (2013) The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009\u201310. Ann Rheum Dis 72(3):369\u2013373","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR187","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/rheumatology\/ken224","volume":"47","author":"RN Jois","year":"2008","unstructured":"Jois\u00a0RN, Macgregor\u00a0AJ, Gaffney\u00a0K (2008) Recognition of inflammatory back pain and ankylosing spondylitis in primary care. Rheumatol (oxford) 47(9):1364\u20131366","journal-title":"Rheumatol (oxford)"},{"issue":"11","key":"670_CR188","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/ard.2006.068734","volume":"66","author":"HC Brandt","year":"2007","unstructured":"Brandt\u00a0HC et\u00a0al (2007) Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis. Ann Rheum Dis 66(11):1479\u20131484","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR189","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/rheumatology\/kep119","volume":"48","author":"J Hermann","year":"2009","unstructured":"Hermann\u00a0J et\u00a0al (2009) Early spondyloarthritis: usefulness of clinical screening. Rheumatol (oxford) 48(7):812\u2013816","journal-title":"Rheumatol (oxford)"},{"issue":"10","key":"670_CR190","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/ard.2011.151167","volume":"70","author":"A Braun","year":"2011","unstructured":"Braun\u00a0A et\u00a0al (2011) Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain? Ann Rheum Dis 70(10):1782\u20131787","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR191","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3899\/jrheum.110070","volume":"38","author":"D Poddubnyy","year":"2011","unstructured":"Poddubnyy\u00a0D et\u00a0al (2011) Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care. J\u00a0Rheumatol 38(11):2452\u20132460","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR192","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3899\/jrheum.090625","volume":"37","author":"PD Sampaio-Barros","year":"2010","unstructured":"Sampaio-Barros\u00a0PD et al (2010) Undifferentiated spondyloarthritis: a\u00a0longterm followup. J\u00a0Rheumatol 37(6):1195\u20131199","journal-title":"J Rheumatol"},{"issue":"2","key":"670_CR193","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jbspin.2006.11.003","volume":"74","author":"J Freeston","year":"2007","unstructured":"Freeston\u00a0J et al (2007) Ankylosing spondylitis, HLA-B27 positivity and the need for biologic therapies. Joint Bone Spine 74(2):140\u2013143","journal-title":"Joint Bone Spine"},{"issue":"11","key":"670_CR194","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1136\/ard.2011.152975","volume":"70","author":"HY Chung","year":"2011","unstructured":"Chung\u00a0HY et al (2011) HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis 70(11):1930\u20131936","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR195","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1136\/annrheumdis-2011-200025","volume":"70","author":"M van Onna","year":"2011","unstructured":"van Onna\u00a0M et al (2011) HLA-B27 and gender independently determine the likelihood of a\u00a0positive MRI of the sacroiliac joints in patients with early inflammatory back pain: a\u00a02-year MRI follow-up study. Ann Rheum Dis 70(11):1981\u20131985","journal-title":"Ann Rheum Dis"},{"key":"670_CR196","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/03009749009097070","volume":"87","author":"A Linssen","year":"1990","unstructured":"Linssen\u00a0A (1990) B27+ disease versus B27\u2212 disease. Scand J Rheumatol Suppl 87:111\u2013118 (discussion 118\u20139)","journal-title":"Scand J Rheumatol Suppl"},{"issue":"4","key":"670_CR197","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/art.1780200401","volume":"20","author":"MA Khan","year":"1977","unstructured":"Khan\u00a0MA, Kushner\u00a0I, Braun\u00a0WE (1977) Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 20(4):909\u2013912","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR198","first-page":"574","volume":"27","author":"TJ Kim","year":"2009","unstructured":"Kim\u00a0TJ et al (2009) HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 27(4):574\u2013579","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"670_CR199","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00296-017-3741-2","volume":"37","author":"H Lin","year":"2017","unstructured":"Lin\u00a0H, Gong\u00a0YZ (2017) Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a\u00a0meta-analysis. Rheumatol Int 37(8):1267\u20131280","journal-title":"Rheumatol Int"},{"issue":"4","key":"670_CR200","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg\u00a0A et al (1999) Relative value of erythrocyte sedimentation rate and C\u2011reactive protein in assessment of disease activity in ankylosing spondylitis. J\u00a0Rheumatol 26(4):980\u2013984","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR201","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/rheumatology\/ket115","volume":"52","author":"A Braun","year":"2013","unstructured":"Braun\u00a0A et al (2013) Optimizing the identification of patients with axial spondyloarthritis in primary care\u2014the case for a\u00a0two-step strategy combining the most relevant clinical items with HLA B27. Rheumatol (oxford) 52(8):1418\u20131424","journal-title":"Rheumatol (oxford)"},{"issue":"3","key":"670_CR202","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/acr.22180","volume":"66","author":"L van Hoeven","year":"2014","unstructured":"van Hoeven\u00a0L et\u00a0al (2014) Identifying axial spondyloarthritis in Dutch primary care patients, ages 20\u201345 years, with chronic low back pain. Arthritis Care Res (hoboken) 66(3):446\u2013453","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"10","key":"670_CR203","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1136\/annrheumdis-2012-201777","volume":"72","author":"J Sieper","year":"2013","unstructured":"Sieper\u00a0J et\u00a0al (2013) Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Ann Rheum Dis 72(10):1621\u20131627","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR204","doi-asserted-by":"publisher","first-page":"e000389","DOI":"10.1136\/rmdopen-2016-000389","volume":"3","author":"O Abawi","year":"2017","unstructured":"Abawi\u00a0O et\u00a0al (2017) Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort. RMD Open 3(1):e389","journal-title":"RMD Open"},{"issue":"5","key":"670_CR205","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/ar2496","volume":"10","author":"X Baraliakos","year":"2008","unstructured":"Baraliakos\u00a0X et\u00a0al (2008) The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 10(5):R104","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"670_CR206","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/art.24132","volume":"60","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych\u00a0WP et\u00a0al (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a\u00a0relationship between inflammation and new bone formation. Arthritis Rheum 60(1):93\u2013102","journal-title":"Arthritis Rheum"},{"issue":"8","key":"670_CR207","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/art.30393","volume":"63","author":"P Chiowchanwisawakit","year":"2011","unstructured":"Chiowchanwisawakit\u00a0P et\u00a0al (2011) Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 63(8):2215\u20132225","journal-title":"Arthritis Rheum"},{"issue":"12","key":"670_CR208","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1002\/art.30627","volume":"63","author":"SJ Pedersen","year":"2011","unstructured":"Pedersen\u00a0SJ et\u00a0al (2011) Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor alpha inhibitors: a\u00a0study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis Rheum 63(12):3789\u20133800","journal-title":"Arthritis Rheum"},{"issue":"7","key":"670_CR209","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3899\/jrheum.100925","volume":"38","author":"SJ Pedersen","year":"2011","unstructured":"Pedersen\u00a0SJ et\u00a0al (2011) Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J\u00a0Rheumatol 38(7):1349\u20131354","journal-title":"J Rheumatol"},{"issue":"7","key":"670_CR210","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/ard.2006.066415","volume":"66","author":"X Baraliakos","year":"2007","unstructured":"Baraliakos\u00a0X et\u00a0al (2007) Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 66(7):910\u2013915","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR211","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra\u00a0D et al (2007) Dickkopf-1 is a\u00a0master regulator of joint remodeling. Nat Med 13(2):156\u2013163","journal-title":"Nat Med"},{"issue":"1","key":"670_CR212","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.27231","volume":"62","author":"D Daoussis","year":"2010","unstructured":"Daoussis\u00a0D et al (2010) Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62(1):150\u2013158","journal-title":"Arthritis Rheum"},{"issue":"11","key":"670_CR213","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel\u00a0H et\u00a0al (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60(11):3257\u20133262","journal-title":"Arthritis Rheum"},{"issue":"7","key":"670_CR214","first-page":"1109","volume":"15","author":"W Mau","year":"1988","unstructured":"Mau\u00a0W et al (1988) Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a\u00a010-year followup. J\u00a0Rheumatol 15(7):1109\u20131114","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR215","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/ard.2010.145995","volume":"70","author":"D Poddubnyy","year":"2011","unstructured":"Poddubnyy\u00a0D et\u00a0al (2011) Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 70(8):1369\u20131374","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR216","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","volume":"76","author":"M Dougados","year":"2017","unstructured":"Dougados\u00a0M et al (2017) Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5\u2011year data of the DESIR cohort. Ann Rheum Dis 76(11):1823\u20131828","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR217","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/art.39542","volume":"68","author":"R Wang","year":"2016","unstructured":"Wang\u00a0R, Gabriel\u00a0SE, Ward\u00a0MM (2016) Progression of Nonradiographic axial Spondyloarthritis to Ankylosing Spondylitis: a population-based cohort study. Arthritis Rheumatol 68(6):1415\u20131421","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"670_CR218","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/art.24425","volume":"61","author":"X Baraliakos","year":"2009","unstructured":"Baraliakos\u00a0X et\u00a0al (2009) Development of a\u00a0radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change. Arthritis Rheum 61(6):764\u2013771","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR219","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00586-014-3491-8","volume":"24","author":"JS Lee","year":"2015","unstructured":"Lee\u00a0JS et\u00a0al (2015) Relationship between cervical sagittal alignment and quality of life in ankylosing spondylitis. Eur Spine\u00a0J 24(6):1199\u20131203","journal-title":"Eur Spine J"},{"issue":"5","key":"670_CR220","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11926-011-0192-8","volume":"13","author":"X Baraliakos","year":"2011","unstructured":"Baraliakos\u00a0X et\u00a0al (2011) The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features. Curr Rheumatol Rep 13(5):383\u2013387","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"670_CR221","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1136\/annrheumdis-2016-209209","volume":"75","author":"D Poddubnyy","year":"2016","unstructured":"Poddubnyy\u00a0D et\u00a0al (2016) High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis 75(12):2114\u20132118","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR222","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/annrheumdis-2011-200411","volume":"71","author":"A van Tubergen","year":"2012","unstructured":"van Tubergen\u00a0A et\u00a0al (2012) Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a\u00a0longitudinal study. Ann Rheum Dis 71(4):518\u2013523","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR223","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro\u00a0S et al (2014) Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 73(8):1455\u20131461","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR224","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/art.33465","volume":"64","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy\u00a0D et al (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64(5):1388\u20131398","journal-title":"Arthritis Rheum"},{"issue":"10","key":"670_CR225","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/art.23901","volume":"58","author":"D van der Heijde","year":"2008","unstructured":"van der Heijde\u00a0D et\u00a0al (2008) Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 58(10):3063\u20133070","journal-title":"Arthritis Rheum"},{"issue":"12","key":"670_CR226","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","volume":"41","author":"K MacKay","year":"1998","unstructured":"MacKay\u00a0K et\u00a0al (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a\u00a0new, validated approach to disease assessment. Arthritis Rheum 41(12):2263\u20132270","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR227","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/rheumatology\/35.4.373","volume":"35","author":"HL Averns","year":"1996","unstructured":"Averns\u00a0HL et\u00a0al (1996) Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 35(4):373\u2013376","journal-title":"Br J Rheumatol"},{"issue":"1","key":"670_CR228","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers\u00a0MC et\u00a0al (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64(1):127\u2013129","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR229","first-page":"67","volume":"25","author":"F Salaffi","year":"2007","unstructured":"Salaffi\u00a0F et\u00a0al (2007) Radiological scoring methods for ankylosing spondylitis: a\u00a0comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol 25(1):67\u201374","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"670_CR230","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/rheumatology\/kev283","volume":"55","author":"F de Bruin","year":"2016","unstructured":"de Bruin\u00a0F et\u00a0al (2016) Prevalence of degenerative changes of the spine on magnetic resonance images and radiographs in patients aged 16\u201345 years with chronic back pain of short duration in the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatol (oxford) 55(1):56\u201365","journal-title":"Rheumatol (oxford)"},{"issue":"11","key":"670_CR231","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/rheumatology\/kem135","volume":"46","author":"D Vosse","year":"2007","unstructured":"Vosse\u00a0D et al (2007) Comparing morphometric X\u2011ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis. Rheumatol (oxford) 46(11):1667\u20131671","journal-title":"Rheumatol (oxford)"},{"issue":"9","key":"670_CR232","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/annrheumdis-2016-210640","volume":"76","author":"T Diekhoff","year":"2017","unstructured":"Diekhoff\u00a0T et\u00a0al (2017) Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study. Ann Rheum Dis 76(9):1502\u20131508","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR233","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1136\/ard.2004.031609","volume":"64","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos\u00a0X et\u00a0al (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a\u00a0comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 64(8):1141\u20131144","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR234","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et\u00a0al (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a\u00a0consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis 68(10):1520\u20131527","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR235","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/art.24507","volume":"61","author":"U Weber","year":"2009","unstructured":"Weber\u00a0U et al (2009) Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain. Arthritis Rheum 61(7):900\u2013908","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR236","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/annrheumdis-2012-201545","volume":"72","author":"CE Althoff","year":"2013","unstructured":"Althoff\u00a0CE et al (2013) Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI. Ann Rheum Dis 72(6):967\u2013973","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR237","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/art.24542","volume":"61","author":"U Weber","year":"2009","unstructured":"Weber\u00a0U et al (2009) Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Arthritis Rheum 61(7):893\u2013899","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR238","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/ard.2009.108274","volume":"69","author":"U Weber","year":"2010","unstructured":"Weber\u00a0U et\u00a0al (2010) Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI. Ann Rheum Dis 69(4):648\u2013653","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR239","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/ard.59.2.135","volume":"59","author":"M Bollow","year":"2000","unstructured":"Bollow\u00a0M et\u00a0al (2000) Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis\u2014cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 59(2):135\u2013140","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR240","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/art.33453","volume":"64","author":"Y Gong","year":"2012","unstructured":"Gong\u00a0Y et\u00a0al (2012) Ten years\u2019 experience with needle biopsy in the early diagnosis of sacroiliitis. Arthritis Rheum 64(5):1399\u20131406","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR241","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/art.10934","volume":"48","author":"B Muche","year":"2003","unstructured":"Muche\u00a0B et al (2003) Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a\u00a0detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 48(5):1374\u20131384","journal-title":"Arthritis Rheum"},{"issue":"1","key":"670_CR242","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/acr.20008","volume":"62","author":"KB Madsen","year":"2010","unstructured":"Madsen\u00a0KB, Jurik\u00a0AG (2010) Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint. Arthritis Care Res (hoboken) 62(1):11\u201318","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"2","key":"670_CR243","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3899\/jrheum.090519","volume":"37","author":"KB Madsen","year":"2010","unstructured":"Madsen\u00a0KB, Egund\u00a0N, Jurik\u00a0AG (2010) Grading of inflammatory disease activity in the sacroiliac joints with magnetic resonance imaging: comparison between short-tau inversion recovery and gadolinium contrast-enhanced sequences. J\u00a0Rheumatol 37(2):393\u2013400","journal-title":"J Rheumatol"},{"issue":"11","key":"670_CR244","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/ard.2008.097931","volume":"68","author":"H Marzo-Ortega","year":"2009","unstructured":"Marzo-Ortega\u00a0H et al (2009) Baseline and 1\u2011year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann Rheum Dis 68(11):1721\u20131727","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR245","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/ard.2010.147033","volume":"70","author":"IH Song","year":"2011","unstructured":"Song\u00a0IH et al (2011) Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis 70(7):1257\u20131263","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR246","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jbspin.2015.05.011","volume":"83","author":"Z Hu","year":"2016","unstructured":"Hu\u00a0Z et\u00a0al (2016) Backfill is a\u00a0specific sign of axial spondyloarthritis seen on MRI. Joint Bone Spine 83(2):179\u2013183","journal-title":"Joint Bone Spine"},{"issue":"3","key":"670_CR247","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3899\/jrheum.090602","volume":"37","author":"MC Wick","year":"2010","unstructured":"Wick\u00a0MC et\u00a0al (2010) Erosions are the most relevant magnetic resonance imaging features in quantification of sacroiliac joints in ankylosing spondylitis. J\u00a0Rheumatol 37(3):622\u2013627","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR248","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/acr.21893","volume":"65","author":"U Weber","year":"2013","unstructured":"Weber\u00a0U et\u00a0al (2013) Development and validation of a\u00a0magnetic resonance imaging reference criterion for defining a\u00a0positive sacroiliac joint magnetic resonance imaging finding in spondyloarthritis. Arthritis Care Res (hoboken) 65(6):977\u2013985","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"10","key":"670_CR249","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1002\/art.27571","volume":"62","author":"U Weber","year":"2010","unstructured":"Weber\u00a0U et al (2010) The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 62(10):3048\u20133058","journal-title":"Arthritis Rheum"},{"issue":"12","key":"670_CR250","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/acr.20312","volume":"62","author":"U Weber","year":"2010","unstructured":"Weber\u00a0U et\u00a0al (2010) Assessment of structural lesions in sacroiliac joints enhances diagnostic utility of magnetic resonance imaging in early spondylarthritis. Arthritis Care Res (hoboken) 62(12):1763\u20131771","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"8","key":"670_CR251","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3899\/jrheum.091155","volume":"37","author":"KB Madsen","year":"2010","unstructured":"Madsen\u00a0KB, Schiottz-Christensen\u00a0B, Jurik\u00a0AG (2010) Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis\u2014a followup study. J\u00a0Rheumatol 37(8):1718\u20131727","journal-title":"J Rheumatol"},{"issue":"11","key":"670_CR252","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1002\/art.24024","volume":"58","author":"AN Bennett","year":"2008","unstructured":"Bennett\u00a0AN et al (2008) Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58(11):3413\u20133418","journal-title":"Arthritis Rheum"},{"issue":"2","key":"670_CR253","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.39434","volume":"68","author":"SJ Pedersen","year":"2016","unstructured":"Pedersen\u00a0SJ et al (2016) Course of magnetic resonance imaging-detected inflammation and structural lesions in the sacroiliac joints of patients in the randomized, double-blind, placebo-controlled Danish Multicenter study of Adalimumab in Spondyloarthritis, as assessed by the berlin and Spondyloarthritis research consortium of Canada methods. Arthritis Rheumatol 68(2):418\u2013429","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"670_CR254","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ard.2004.029298","volume":"64","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos\u00a0X et\u00a0al (2005) Inflammation in ankylosing spondylitis: a\u00a0systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 64(5):730\u2013734","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR255","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/art.24561","volume":"61","author":"WJ Rennie","year":"2009","unstructured":"Rennie\u00a0WJ et\u00a0al (2009) Magnetic resonance imaging assessment of spinal inflammation in ankylosing spondylitis: standard clinical protocols may omit inflammatory lesions in thoracic vertebrae. Arthritis Rheum 61(9):1187\u20131193","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR256","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar2035","volume":"8","author":"H Appel","year":"2006","unstructured":"Appel\u00a0H et\u00a0al (2006) Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 8(5):R143","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"670_CR257","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s002560050005","volume":"29","author":"V Jevtic","year":"2000","unstructured":"Jevtic\u00a0V et al (2000) Marginal erosive discovertebral \u201cRomanus\u201d lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging. Skeletal Radiol 29(1):27\u201333","journal-title":"Skeletal Radiol."},{"issue":"2","key":"670_CR258","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/17453675208988998","volume":"22","author":"R Romanus","year":"1952","unstructured":"Romanus\u00a0R, Yden\u00a0S (1952) Destructive and ossifying spondylitic changes in rheumatoid ankylosing spondylitis (pelvo-spondylitis ossificans). Acta Orthop Scand 22(2):88\u201399","journal-title":"Acta Orthop Scand"},{"issue":"5","key":"670_CR259","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/art.24493","volume":"60","author":"AN Bennett","year":"2009","unstructured":"Bennett\u00a0AN et\u00a0al (2009) Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondylarthritis. Arthritis Rheum 60(5):1331\u20131341","journal-title":"Arthritis Rheum"},{"issue":"750","key":"670_CR260","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1259\/0007-1285-63-750-448","volume":"63","author":"JB Kenny","year":"1990","unstructured":"Kenny\u00a0JB, Hughes\u00a0PL, Whitehouse\u00a0GH (1990) Discovertebral destruction in ankylosing spondylitis: the role of computed tomography and magnetic resonance imaging. Br J Radiol 63(750):448\u2013455","journal-title":"Br J Radiol"},{"issue":"7","key":"670_CR261","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/rheumatology\/35.7.660","volume":"35","author":"Y Kabasakal","year":"1996","unstructured":"Kabasakal\u00a0Y, Garrett\u00a0SL, Calin\u00a0A (1996) The epidemiology of spondylodiscitis in ankylosing spondylitis\u2014a controlled study. Br J Rheumatol 35(7):660\u2013663","journal-title":"Br J Rheumatol"},{"issue":"5","key":"670_CR262","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/ard.2009.112094","volume":"69","author":"AN Bennett","year":"2010","unstructured":"Bennett\u00a0AN et al (2010) The fatty Romanus lesion: a\u00a0non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy. Ann Rheum Dis 69(5):891\u2013894","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR263","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/ard.2003.019968","volume":"63","author":"J Braun","year":"2004","unstructured":"Braun\u00a0J et\u00a0al (2004) Analysing chronic spinal changes in ankylosing spondylitis: a\u00a0systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63(9):1046\u20131055","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR264","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/art.10883","volume":"48","author":"J Braun","year":"2003","unstructured":"Braun\u00a0J et\u00a0al (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a\u00a0new scoring system. Arthritis Rheum 48(4):1126\u20131136","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR265","first-page":"871","volume":"34","author":"D van der Heijde","year":"2007","unstructured":"van der Heijde\u00a0D et\u00a0al (2007) Is there a\u00a0preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis? J\u00a0Rheumatol 34(4):871\u2013873","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR266","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/art.21445","volume":"53","author":"WP Maksymowych","year":"2005","unstructured":"Maksymowych\u00a0WP et\u00a0al (2005) Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 53(5):703\u2013709","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR267","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/art.22627","volume":"57","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych\u00a0WP et\u00a0al (2007) Validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging spinal inflammation index: is it necessary to score the entire spine? Arthritis Rheum 57(3):501\u2013507","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR268","first-page":"862","volume":"34","author":"C Lukas","year":"2007","unstructured":"Lukas\u00a0C et\u00a0al (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a\u00a0multireader experiment. J\u00a0Rheumatol 34(4):862\u2013870","journal-title":"J Rheumatol"},{"issue":"1","key":"670_CR269","first-page":"126","volume":"35","author":"M Treitl","year":"2008","unstructured":"Treitl\u00a0M et\u00a0al (2008) Magnetic resonance imaging assessment of spinal inflammation in patients treated for ankylosing spondylitis. J\u00a0Rheumatol 35(1):126\u2013136","journal-title":"J Rheumatol"},{"issue":"7","key":"670_CR270","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1136\/annrheumdis-2011-200508","volume":"71","author":"U Kiltz","year":"2012","unstructured":"Kiltz\u00a0U et\u00a0al (2012) The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a\u00a0cohort study. Ann Rheum Dis 71(7):1207\u20131211","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR271","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.crad.2009.08.009","volume":"65","author":"KB Madsen","year":"2010","unstructured":"Madsen\u00a0KB, Jurik\u00a0AG (2010) MRI grading method for active and chronic spinal changes in spondyloarthritis. Clin Radiol 65(1):6\u201314","journal-title":"Clin Radiol"},{"issue":"6","key":"670_CR272","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/annrheumdis-2013-203887","volume":"74","author":"U Weber","year":"2015","unstructured":"Weber\u00a0U et al (2015) Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis? Ann Rheum Dis 74(6):985\u2013992","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR273","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/ard.2011.150680","volume":"71","author":"KG Hermann","year":"2012","unstructured":"Hermann\u00a0KG et\u00a0al (2012) Descriptions of spinal MRI lesions and definition of a\u00a0positive MRI of the spine in axial spondyloarthritis: a\u00a0consensual approach by the ASAS\/OMERACT MRI study group. Ann Rheum Dis 71(8):1278\u20131288","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR274","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1136\/ard.2007.073098","volume":"67","author":"M Rudwaleit","year":"2008","unstructured":"Rudwaleit\u00a0M et al (2008) MRI in predicting a\u00a0major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67(9):1276\u20131281","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR275","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"J Braun","year":"2006","unstructured":"Braun\u00a0J et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a\u00a0multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54(5):1646\u20131652","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR276","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/art.21588","volume":"53","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos\u00a0X et\u00a0al (2005) Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum 53(6):856\u2013863","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR277","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/art.20977","volume":"52","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos\u00a0X et\u00a0al (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52(4):1216\u20131223","journal-title":"Arthritis Rheum"},{"issue":"12","key":"670_CR278","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/rheumatology\/kei046","volume":"44","author":"J Sieper","year":"2005","unstructured":"Sieper\u00a0J et al (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatol (oxford) 44(12):1525\u20131530","journal-title":"Rheumatol (oxford)"},{"issue":"9","key":"670_CR279","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1136\/ard.2008.092213","volume":"68","author":"SJ Jarrett","year":"2009","unstructured":"Jarrett\u00a0SJ et al (2009) MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a\u00a0short course of etoricoxib. Ann Rheum Dis 68(9):1466\u20131469","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR280","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/annrheumdis-2011-200336","volume":"71","author":"A Feydy","year":"2012","unstructured":"Feydy\u00a0A et\u00a0al (2012) Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls. Ann Rheum Dis 71(4):498\u2013503","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR281","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/ard.2008.093351","volume":"68","author":"A Spadaro","year":"2009","unstructured":"Spadaro\u00a0A et al (2009) Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis. Ann Rheum Dis 68(10):1559\u20131563","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR282","first-page":"110","volume":"34","author":"E Unlu","year":"2007","unstructured":"Unlu\u00a0E, Pamuk\u00a0ON, Cakir\u00a0N (2007) Color and duplex Doppler sonography to detect sacroiliitis and spinal inflammation in ankylosing spondylitis. Can this method reveal response to anti-tumor necrosis factor therapy? J\u00a0Rheumatol 34(1):110\u2013116","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR283","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1136\/ard.2009.127175","volume":"69","author":"SZ Aydin","year":"2010","unstructured":"Aydin\u00a0SZ et\u00a0al (2010) Validation of ultrasound imaging for Achilles entheseal fibrocartilage in bovines and description of changes in humans with spondyloarthritis. Ann Rheum Dis 69(12):2165\u20132168","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR284","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1136\/ard.2010.138701","volume":"70","author":"MA D\u2019Agostino","year":"2011","unstructured":"D\u2019Agostino\u00a0MA et\u00a0al (2011) How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography. Ann Rheum Dis 70(8):1433\u20131440","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR285","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/ard.2010.134965","volume":"70","author":"E de Miguel","year":"2011","unstructured":"de Miguel\u00a0E et\u00a0al (2011) Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis. Ann Rheum Dis 70(3):434\u2013439","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR286","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard.2007.084251","volume":"68","author":"E de Miguel","year":"2009","unstructured":"de Miguel\u00a0E et\u00a0al (2009) Validity of enthesis ultrasound assessment in spondyloarthropathy. Ann Rheum Dis 68(2):169\u2013174","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR287","doi-asserted-by":"publisher","first-page":"e000482","DOI":"10.1136\/rmdopen-2017-000482","volume":"3","author":"A Ruyssen-Witrand","year":"2017","unstructured":"Ruyssen-Witrand\u00a0A et al (2017) Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort. RMD Open 3(2):e482","journal-title":"RMD Open"},{"issue":"11","key":"670_CR288","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1136\/ard.2007.083089","volume":"67","author":"IH Song","year":"2008","unstructured":"Song\u00a0IH et\u00a0al (2008) The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a\u00a0systematic literature research. Ann Rheum Dis 67(11):1535\u20131540","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR289","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3899\/jrheum.091216","volume":"37","author":"IH Song","year":"2010","unstructured":"Song\u00a0IH et\u00a0al (2010) Limited diagnostic value of unilateral sacroiliitis in scintigraphy in assessing axial spondyloarthritis. J\u00a0Rheumatol 37(6):1200\u20131202","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR290","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/art.33466","volume":"64","author":"V Devauchelle-Pensec","year":"2012","unstructured":"Devauchelle-Pensec\u00a0V et al (2012) Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a\u00a0prospective multicenter French cohort study. Arthritis Rheum 64(5):1412\u20131419","journal-title":"Arthritis Rheum"},{"issue":"9","key":"670_CR291","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00259-010-1464-7","volume":"37","author":"K Strobel","year":"2010","unstructured":"Strobel\u00a0K et al (2010) 18F-fluoride PET\/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging 37(9):1760\u20131765","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"670_CR292","first-page":"971","volume":"26","author":"M Dougados","year":"1999","unstructured":"Dougados\u00a0M et al (1999) Clinical relevance of C\u2011reactive protein in axial involvement of ankylosing spondylitis. J\u00a0Rheumatol 26(4):971\u2013974","journal-title":"J Rheumatol"},{"issue":"3","key":"670_CR293","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/rheumatology\/kep393","volume":"49","author":"M Benhamou","year":"2010","unstructured":"Benhamou\u00a0M, Gossec\u00a0L, Dougados\u00a0M (2010) Clinical relevance of C\u2011reactive protein in ankylosing spondylitis and evaluation of the NSAIDs\/coxibs\u2019 treatment effect on C\u2011reactive protein. Rheumatol (oxford) 49(3):536\u2013541","journal-title":"Rheumatol (oxford)"},{"issue":"10","key":"670_CR294","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","volume":"71","author":"F Kroon","year":"2012","unstructured":"Kroon\u00a0F et\u00a0al (2012) Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 71(10):1623\u20131629","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR295","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy\u00a0D et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71(10):1616\u20131622","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR296","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1136\/ard.2009.120139","volume":"69","author":"DA Poddubnyy","year":"2010","unstructured":"Poddubnyy\u00a0DA et al (2010) Comparison of a\u00a0high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 69(7):1338\u20131341","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR297","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/art.24838","volume":"61","author":"MK de Vries","year":"2009","unstructured":"de Vries\u00a0MK et al (2009) Erythrocyte sedimentation rate, C\u2011reactive protein level, and serum amyloid a\u00a0protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum 61(11):1484\u20131490","journal-title":"Arthritis Rheum"},{"issue":"1","key":"670_CR298","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","volume":"19","author":"E Klingberg","year":"2017","unstructured":"Klingberg\u00a0E et\u00a0al (2017) A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis. Arthritis Res Ther 19(1):21","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"670_CR299","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","volume":"75","author":"H Cypers","year":"2016","unstructured":"Cypers\u00a0H et\u00a0al (2016) Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis 75(7):1357\u20131362","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"670_CR300","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde\u00a0D et al (2009) ASDAS, a\u00a0highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811\u20131818","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR301","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00393-003-0522-y","volume":"62","author":"J Brandt","year":"2003","unstructured":"Brandt\u00a0J et\u00a0al (2003) Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z\u00a0Rheumatol 62(3):264\u2013273","journal-title":"Z Rheumatol"},{"issue":"1","key":"670_CR302","first-page":"80","volume":"32","author":"S Pavy","year":"2005","unstructured":"Pavy\u00a0S, Brophy\u00a0S, Calin\u00a0A (2005) Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a\u00a0prospective study. J\u00a0Rheumatol 32(1):80\u201385","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR303","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","volume":"43","author":"J Brandt","year":"2000","unstructured":"Brandt\u00a0J et al (2000) Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43(6):1346\u20131352","journal-title":"Arthritis Rheum"},{"issue":"2","key":"670_CR304","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jbspin.2007.05.018","volume":"75","author":"JM Berthelot","year":"2008","unstructured":"Berthelot\u00a0JM et al (2008) High intraindividual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondyloarthropathies? Joint Bone Spine 75(2):167\u2013171","journal-title":"Joint Bone Spine"},{"issue":"11","key":"670_CR305","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1136\/ard.2008.099226","volume":"68","author":"IH Song","year":"2009","unstructured":"Song\u00a0IH et\u00a0al (2009) Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a\u00a0modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations. Ann Rheum Dis 68(11):1701\u20131707","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR306","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/art.38921","volume":"67","author":"P Machado","year":"2015","unstructured":"Machado\u00a0P et al (2015) Calculating the ankylosing spondylitis disease activity score if the conventional c\u2011reactive protein level is below the limit of detection or if high-sensitivity c\u2011reactive protein is used: an analysis in the DESIR cohort. Arthritis Rheumatol 67(2):408\u2013413","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"670_CR307","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado\u00a0P et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47\u201353","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR308","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1756-185X.2010.01537.x","volume":"13","author":"K Nas","year":"2010","unstructured":"Nas\u00a0K et\u00a0al (2010) Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis. Int J Rheum Dis 13(3):240\u2013245","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"670_CR309","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/ard.2009.111187","volume":"69","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen\u00a0SJ et al (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a\u00a01-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69(6):1065\u20131071","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR310","first-page":"752","volume":"28","author":"SZ Aydin","year":"2010","unstructured":"Aydin\u00a0SZ et al (2010) Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a\u00a0prospective, follow-up of disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol 28(5):752\u2013755","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"670_CR311","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.reuma.2013.12.006","volume":"10","author":"N Vastesaeger","year":"2014","unstructured":"Vastesaeger\u00a0N et al (2014) ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy. Reumatol Clin 10(4):204\u2013209","journal-title":"Reumatol Clin"},{"issue":"6","key":"670_CR312","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00296-014-3168-y","volume":"35","author":"E Kilic","year":"2015","unstructured":"Kilic\u00a0E et al (2015) Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a\u00a0cohort study. Rheumatol Int 35(6):981\u2013989","journal-title":"Rheumatol Int"},{"issue":"9","key":"670_CR313","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/1756-185X.12885","volume":"20","author":"G Kilic","year":"2017","unstructured":"Kilic\u00a0G, Kilic\u00a0E, Ozgocmen\u00a0S (2017) Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis? Int J Rheum Dis 20(9):1201\u20131211","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"670_CR314","doi-asserted-by":"publisher","first-page":"e000033","DOI":"10.1136\/rmdopen-2014-000033","volume":"1","author":"D Huscher","year":"2015","unstructured":"Huscher\u00a0D et\u00a0al (2015) Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012. RMD Open 1(1):e33","journal-title":"RMD Open"},{"issue":"2","key":"670_CR315","first-page":"316","volume":"30","author":"MF Doran","year":"2003","unstructured":"Doran\u00a0MF et\u00a0al (2003) Predictors of longterm outcome in ankylosing spondylitis. J\u00a0Rheumatol 30(2):316\u2013320","journal-title":"J Rheumatol"},{"issue":"10","key":"670_CR316","first-page":"1883","volume":"21","author":"B Amor","year":"1994","unstructured":"Amor\u00a0B et\u00a0al (1994) Predictive factors for the longterm outcome of spondyloarthropathies. J\u00a0Rheumatol 21(10):1883\u20131887","journal-title":"J Rheumatol"},{"issue":"7","key":"670_CR317","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/rheumatology\/36.7.766","volume":"36","author":"JT Gran","year":"1997","unstructured":"Gran\u00a0JT, Skomsvoll\u00a0JF (1997) The outcome of ankylosing spondylitis: a\u00a0study of 100 patients. Br J Rheumatol 36(7):766\u2013771","journal-title":"Br J Rheumatol"},{"issue":"3","key":"670_CR318","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/03009749609080003","volume":"25","author":"HL Averns","year":"1996","unstructured":"Averns\u00a0HL et\u00a0al (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25(3):138\u2013142","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"670_CR319","first-page":"1420","volume":"29","author":"MM Ward","year":"2002","unstructured":"Ward\u00a0MM (2002) Predictors of the progression of functional disability in patients with ankylosing spondylitis. J\u00a0Rheumatol 29(7):1420\u20131425","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR320","first-page":"1236","volume":"29","author":"S Brophy","year":"2002","unstructured":"Brophy\u00a0S et\u00a0al (2002) The natural history of ankylosing spondylitis as defined by radiological progression. J\u00a0Rheumatol 29(6):1236\u20131243","journal-title":"J Rheumatol"},{"issue":"11","key":"670_CR321","first-page":"2225","volume":"24","author":"D van der Heijde","year":"1997","unstructured":"van der Heijde\u00a0D et\u00a0al (1997) Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J\u00a0Rheumatol 24(11):2225\u20132229","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR322","first-page":"1003","volume":"26","author":"D van der Heijde","year":"1999","unstructured":"van der Heijde\u00a0D et\u00a0al (1999) Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J\u00a0Rheumatol 26(4):1003\u20131005","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR323","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"JJ Anderson","year":"2001","unstructured":"Anderson\u00a0JJ et al (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44(8):1876\u20131886","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR324","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2011-200358","volume":"71","author":"J Sieper","year":"2012","unstructured":"Sieper\u00a0J et al (2012) Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis. Ann Rheum Dis 71(5):700\u2013706","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR325","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1186\/ar3054","volume":"12","author":"M Rudwaleit","year":"2010","unstructured":"Rudwaleit\u00a0M et al (2010) Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy. Arthritis Res Ther 12(3):R117","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"670_CR326","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1136\/ard.2009.124446","volume":"69","author":"B Glintborg","year":"2010","unstructured":"Glintborg\u00a0B et al (2010) Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years\u2019 surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis 69(11):2002\u20132008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR327","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/rheumatology\/kep422","volume":"49","author":"PA Lord","year":"2010","unstructured":"Lord\u00a0PA et al (2010) Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register. Rheumatol (oxford) 49(3):563\u2013570","journal-title":"Rheumatol (oxford)"},{"issue":"3","key":"670_CR328","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4081\/reumatismo.2014.756","volume":"66","author":"FM Perrotta","year":"2014","unstructured":"Perrotta\u00a0FM et al (2014) Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFalpha drugs. Reumatismo 66(3):208\u2013214","journal-title":"Reumatismo"},{"issue":"9","key":"670_CR329","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/annrheumdis-2018-213585","volume":"77","author":"AK Rausch Osthoff","year":"2018","unstructured":"Rausch Osthoff\u00a0AK et\u00a0al (2018) EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77(9):1251\u20131260","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR330","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/rheumatology\/kew277","volume":"55","author":"BN Klemz","year":"2016","unstructured":"Klemz\u00a0BN et\u00a0al (2016) The relevance of performing exercise test before starting supervised physical exercise in asymptomatic cardiovascular patients with rheumatic diseases. Rheumatol (oxford) 55(11):1978\u20131986","journal-title":"Rheumatol (oxford)"},{"issue":"1","key":"670_CR331","first-page":"CD002822","volume":"2008","author":"H Dagfinrud","year":"2008","unstructured":"Dagfinrud\u00a0H, Kvien\u00a0TK, Hagen\u00a0KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2008(1):CD2822","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"670_CR332","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/1529-0131(200110)45:5<430::AID-ART362>3.0.CO;2-F","volume":"45","author":"A van Tubergen","year":"2001","unstructured":"van Tubergen\u00a0A et al (2001) Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a\u00a0randomized controlled trial. Arthritis Rheum 45(5):430\u2013438","journal-title":"Arthritis Rheum"},{"issue":"2","key":"670_CR333","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jbspin.2015.05.008","volume":"83","author":"C Escalas","year":"2016","unstructured":"Escalas\u00a0C et\u00a0al (2016) Evaluation of physiotherapy in a\u00a0prospective cohort of early axial spondyloarthritis. Data from the DESIR cohort. Joint Bone Spine 83(2):185\u2013190","journal-title":"Joint Bone Spine"},{"key":"670_CR334","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0042-116425","volume":"42","author":"K Albrecht","year":"2017","unstructured":"Albrecht\u00a0K, Huscher\u00a0D (2017) Do we prescribe physical medicine sufficiently? Current data from the German Collaborative Arthritis Center. Akt Rheumatol 42:118\u2013121","journal-title":"Akt Rheumatol"},{"issue":"4","key":"670_CR335","first-page":"298","volume":"39","author":"NA Martins","year":"2014","unstructured":"Martins\u00a0NA et al (2014) Exercise and ankylosing spondylitis with New York modified criteria: a\u00a0systematic review of controlled trials with meta-analysis. Acta Reumatol Port 39(4):298\u2013308","journal-title":"Acta Reumatol Port"},{"issue":"2","key":"670_CR336","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1573397112666161025112750","volume":"13","author":"D Sharan","year":"2017","unstructured":"Sharan\u00a0D, Rajkumar\u00a0JS (2017) Physiotherapy for Ankylosing Spondylitis: systematic review and a\u00a0proposed rehabilitation protocol. Curr Rheumatol Rev 13(2):121\u2013125","journal-title":"Curr Rheumatol Rev"},{"issue":"12","key":"670_CR337","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3899\/jrheum.150518","volume":"42","author":"F Jennings","year":"2015","unstructured":"Jennings\u00a0F et\u00a0al (2015) Effects of aerobic training in patients with Ankylosing Spondylitis. J\u00a0Rheumatol 42(12):2347\u20132353","journal-title":"J Rheumatol"},{"issue":"10","key":"670_CR338","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s10067-015-2913-2","volume":"34","author":"H Liang","year":"2015","unstructured":"Liang\u00a0H et al (2015) Effects of home-based exercise intervention on health-related quality of life for patients with ankylosing spondylitis: a\u00a0meta-analysis. Clin Rheumatol 34(10):1737\u20131744","journal-title":"Clin Rheumatol"},{"issue":"11","key":"670_CR339","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/acr.22062","volume":"65","author":"K Niedermann","year":"2013","unstructured":"Niedermann\u00a0K et\u00a0al (2013) Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitis. Arthritis Care Res (hoboken) 65(11):1844\u20131852","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"3","key":"670_CR340","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00296-013-2869-y","volume":"34","author":"MO Rosu","year":"2014","unstructured":"Rosu\u00a0MO et\u00a0al (2014) Effects of Pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a\u00a0randomized controlled trial. Rheumatol Int 34(3):367\u2013372","journal-title":"Rheumatol Int"},{"issue":"7","key":"670_CR341","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00296-011-1932-9","volume":"32","author":"L Altan","year":"2012","unstructured":"Altan\u00a0L et\u00a0al (2012) Effect of Pilates training on people with ankylosing spondylitis. Rheumatol Int 32(7):2093\u20132099","journal-title":"Rheumatol Int"},{"issue":"4","key":"670_CR342","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3899\/jrheum.090655","volume":"37","author":"LA Passalent","year":"2010","unstructured":"Passalent\u00a0LA et\u00a0al (2010) Exercise in ankylosing spondylitis: discrepancies between recommendations and reality. J\u00a0Rheumatol 37(4):835\u2013841","journal-title":"J Rheumatol"},{"issue":"12","key":"670_CR343","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s10067-013-2320-5","volume":"32","author":"C Fongen","year":"2013","unstructured":"Fongen\u00a0C, Halvorsen\u00a0S, Dagfinrud\u00a0H (2013) High disease activity is related to low levels of physical activity in patients with ankylosing spondylitis. Clin Rheumatol 32(12):1719\u20131725","journal-title":"Clin Rheumatol"},{"issue":"3","key":"670_CR344","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2340\/16501977-1078","volume":"45","author":"I Kjeken","year":"2013","unstructured":"Kjeken\u00a0I et al (2013) A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J\u00a0Rehabil Med 45(3):260\u2013267","journal-title":"J Rehabil Med"},{"issue":"6","key":"670_CR345","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/0269215513512214","volume":"28","author":"S Masiero","year":"2014","unstructured":"Masiero\u00a0S et al (2014) Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a\u00a0controlled clinical trial with a\u00a012-month follow-up. Clin Rehabil 28(6):562\u2013572","journal-title":"Clin Rehabil"},{"issue":"6","key":"670_CR346","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00296-008-0756-8","volume":"29","author":"D Durmus","year":"2009","unstructured":"Durmus\u00a0D et al (2009) Effects of a\u00a0home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitis. Rheumatol Int 29(6):673\u2013677","journal-title":"Rheumatol Int"},{"issue":"2","key":"670_CR347","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jbspin.2008.06.013","volume":"76","author":"D Durmus","year":"2009","unstructured":"Durmus\u00a0D et\u00a0al (2009) Effects of two exercise interventions on pulmonary functions in the patients with ankylosing spondylitis. Joint Bone Spine 76(2):150\u2013155","journal-title":"Joint Bone Spine"},{"issue":"4","key":"670_CR348","first-page":"449","volume":"45","author":"H Karapolat","year":"2009","unstructured":"Karapolat\u00a0H et\u00a0al (2009) Are swimming or aerobic exercise better than conventional exercise in ankylosing spondylitis patients? A randomized controlled study. Eur J Phys Rehabil Med 45(4):449\u2013457","journal-title":"Eur J Phys Rehabil Med"},{"issue":"7","key":"670_CR349","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0269215508101748","volume":"23","author":"K Widberg","year":"2009","unstructured":"Widberg\u00a0K, Karimi\u00a0H, Hafstrom\u00a0I (2009) Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis\u2014a randomized study. Clin Rehabil 23(7):599\u2013608","journal-title":"Clin Rehabil"},{"issue":"1","key":"670_CR350","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10067-011-1791-5","volume":"31","author":"E Aytekin","year":"2012","unstructured":"Aytekin\u00a0E et al (2012) Home-based exercise therapy in patients with ankylosing spondylitis: effects on pain, mobility, disease activity, quality of life, and respiratory functions. Clin Rheumatol 31(1):91\u201397","journal-title":"Clin Rheumatol"},{"issue":"4","key":"670_CR351","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1177\/039463200902200430","volume":"22","author":"M Colina","year":"2009","unstructured":"Colina\u00a0M et\u00a0al (2009) Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 22(4):1125\u20131129","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"5","key":"670_CR352","doi-asserted-by":"publisher","first-page":"931","DOI":"10.17219\/acem\/32590","volume":"25","author":"AY Karahan","year":"2016","unstructured":"Karahan\u00a0AY et\u00a0al (2016) The effectiveness of Exergames in patients with Ankylosing Spondylitis: a randomized controlled trial. Adv Clin Exp Med 25(5):931\u2013936","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"670_CR353","first-page":"228","volume":"17","author":"G Kraag","year":"1990","unstructured":"Kraag\u00a0G et\u00a0al (1990) The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis\u2014a randomized controlled trial. J\u00a0Rheumatol 17(2):228\u2013233","journal-title":"J Rheumatol"},{"issue":"7","key":"670_CR354","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ptj\/86.7.924","volume":"86","author":"G Ince","year":"2006","unstructured":"Ince\u00a0G et\u00a0al (2006) Effects of a\u00a0multimodal exercise program for people with ankylosing spondylitis. Phys Ther 86(7):924\u2013935","journal-title":"Phys Ther"},{"issue":"3","key":"670_CR355","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00296-004-0536-z","volume":"25","author":"HJ Lim","year":"2005","unstructured":"Lim\u00a0HJ, Moon\u00a0YI, Lee\u00a0MS (2005) Effects of home-based daily exercise therapy on joint mobility, daily activity, pain, and depression in patients with ankylosing spondylitis. Rheumatol Int 25(3):225\u2013229","journal-title":"Rheumatol Int"},{"issue":"2","key":"670_CR356","first-page":"261","volume":"21","author":"G Kraag","year":"1994","unstructured":"Kraag\u00a0G et al (1994) The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis\u2014an 8\u2011month followup. J\u00a0Rheumatol 21(2):261\u2013263","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR357","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10067-007-0765-0","volume":"27","author":"H Karapolat","year":"2008","unstructured":"Karapolat\u00a0H et al (2008) Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and depression. Clin Rheumatol 27(6):695\u2013700","journal-title":"Clin Rheumatol"},{"issue":"3","key":"670_CR358","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/art.1790060303","volume":"6","author":"A Hidding","year":"1993","unstructured":"Hidding\u00a0A et\u00a0al (1993) Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trial. Arthritis Care Res 6(3):117\u2013125","journal-title":"Arthritis Care Res"},{"key":"670_CR359","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0031-9406(05)66956-8","volume":"82","author":"P Helliwell","year":"1996","unstructured":"Helliwell\u00a0P (1996) A randomised trial of three different physiotherapy regimes in ankylosing spondylitis. Physiotherapy 82:85\u201390","journal-title":"Physiotherapy"},{"issue":"6","key":"670_CR360","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1191\/0269215503cr658oa","volume":"17","author":"Y Analay","year":"2003","unstructured":"Analay\u00a0Y et\u00a0al (2003) The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clin Rehabil 17(6):631\u2013636","journal-title":"Clin Rehabil"},{"issue":"2","key":"670_CR361","first-page":"264","volume":"21","author":"C Bakker","year":"1994","unstructured":"Bakker\u00a0C et\u00a0al (1994) Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial. J\u00a0Rheumatol 21(2):264\u2013268","journal-title":"J Rheumatol"},{"issue":"1","key":"670_CR362","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00296-011-2147-9","volume":"33","author":"L Ciprian","year":"2013","unstructured":"Ciprian\u00a0L et\u00a0al (2013) The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors. Rheumatol Int 33(1):241\u2013245","journal-title":"Rheumatol Int"},{"issue":"7","key":"670_CR363","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10067-008-0873-5","volume":"27","author":"E Gurcay","year":"2008","unstructured":"Gurcay\u00a0E et\u00a0al (2008) Stanger bath therapy for ankylosing spondylitis: illusion or reality? Clin Rheumatol 27(7):913\u2013917","journal-title":"Clin Rheumatol"},{"issue":"4","key":"670_CR364","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/03009740500428806","volume":"35","author":"L Altan","year":"2006","unstructured":"Altan\u00a0L et\u00a0al (2006) The effect of balneotherapy on patients with ankylosing spondylitis. Scand J Rheumatol 35(4):283\u2013289","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"670_CR365","first-page":"443","volume":"7","author":"S Codish","year":"2005","unstructured":"Codish\u00a0S et\u00a0al (2005) Spa therapy for ankylosing spondylltis at the Dead Sea. Isr Med Assoc\u00a0J 7(7):443\u2013446","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"670_CR366","first-page":"81","volume":"49","author":"SM Rutherford","year":"2005","unstructured":"Rutherford\u00a0SM, Nicolson\u00a0CF, Crowther\u00a0ER (2005) Symptomatic improvement in function and disease activity in a\u00a0patient with ankylosing spondylitis utilizing a\u00a0course of chiropractic therapy: a\u00a0prospective case study. J\u00a0Can Chiropr Assoc 49(2):81\u201391","journal-title":"J Can Chiropr Assoc"},{"issue":"1","key":"670_CR367","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10067-008-0977-y","volume":"28","author":"FG Oosterveld","year":"2009","unstructured":"Oosterveld\u00a0FG et al (2009) Infrared sauna in patients with rheumatoid arthritis and ankylosing spondylitis. A pilot study showing good tolerance, short-term improvement of pain and stiffness, and a\u00a0trend towards long-term beneficial effects. Clin Rheumatol 28(1):29\u201334","journal-title":"Clin Rheumatol"},{"issue":"4","key":"670_CR368","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10067-008-1059-x","volume":"28","author":"IH Tarner","year":"2009","unstructured":"Tarner\u00a0IH et al (2009) The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis. Clin Rheumatol 28(4):397\u2013402","journal-title":"Clin Rheumatol"},{"issue":"3","key":"670_CR369","first-page":"127","volume":"51","author":"W Samborski","year":"1992","unstructured":"Samborski\u00a0W et\u00a0al (1992) Can thermal therapy of ankylosing spondylitis induce an activation of the disease? Z\u00a0Rheumatol 51(3):127\u2013131","journal-title":"Z Rheumatol"},{"issue":"6","key":"670_CR370","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/art.1780340624","volume":"34","author":"G Gemignani","year":"1991","unstructured":"Gemignani\u00a0G et al (1991) Transcutaneous electrical nerve stimulation in ankylosing spondylitis: a\u00a0double-blind study. Arthritis Rheum 34(6):788\u2013789","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR371","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00296-013-2941-7","volume":"34","author":"Y Turan","year":"2014","unstructured":"Turan\u00a0Y et al (2014) Is magnetotherapy applied to bilateral hips effective in ankylosing spondylitis patients? A randomized, double-blind, controlled study. Rheumatol Int 34(3):357\u2013365","journal-title":"Rheumatol Int"},{"issue":"5","key":"670_CR372","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00296-016-3441-3","volume":"36","author":"D Silte Karamanlioglu","year":"2016","unstructured":"Silte Karamanlioglu\u00a0D et al (2016) Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a\u00a0double-blind, randomized, placebo-controlled trial. Rheumatol Int 36(5):653\u2013661","journal-title":"Rheumatol Int"},{"issue":"1","key":"670_CR373","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jbspin.2007.07.006","volume":"75","author":"A Spadaro","year":"2008","unstructured":"Spadaro\u00a0A et al (2008) Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs. Joint Bone Spine 75(1):29\u201333","journal-title":"Joint Bone Spine"},{"issue":"9","key":"670_CR374","first-page":"1805","volume":"33","author":"A Barkhuizen","year":"2006","unstructured":"Barkhuizen\u00a0A et\u00a0al (2006) Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis. J\u00a0Rheumatol 33(9):1805\u20131812","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR375","first-page":"1167","volume":"16","author":"M Dougados","year":"1989","unstructured":"Dougados\u00a0M et\u00a0al (1989) A double blind crossover placebo controlled trial of ximoprofen in as. J\u00a0Rheumatol 16(8):1167\u20131169","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR376","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/03009749409103723","volume":"23","author":"M Dougados","year":"1994","unstructured":"Dougados\u00a0M et\u00a0al (1994) Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study. Scand J Rheumatol 23(5):243\u2013248","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"670_CR377","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/ard.33.2.129","volume":"33","author":"RD Sturrock","year":"1974","unstructured":"Sturrock\u00a0RD, Hart\u00a0FD (1974) Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis. Ann Rheum Dis 33(2):129\u2013131","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR378","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.20985","volume":"52","author":"D van der Heijde","year":"2005","unstructured":"van der Heijde\u00a0D et al (2005) Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a\u00a0fifty-two-week, randomized, controlled study. Arthritis Rheum 52(4):1205\u20131215","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR379","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3899\/jrheum.150721","volume":"43","author":"FP Kroon","year":"2016","unstructured":"Kroon\u00a0FP et\u00a0al (2016) Nonsteroidal antiinflammatory drugs for axial Spondyloarthritis: a Cochrane review. J\u00a0Rheumatol 43(3):607\u2013617","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR380","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/annrheumdis-2015-207677","volume":"75","author":"R Wang","year":"2016","unstructured":"Wang\u00a0R, Dasgupta\u00a0A, Ward\u00a0MM (2016) Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a\u00a0Bayesian network meta-analysis of clinical trials. Ann Rheum Dis 75(6):1152\u20131160","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR381","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper\u00a0J et al (2014) Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Ann Rheum Dis 73(1):101\u2013107","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR382","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1136\/ard.2004.029611","volume":"64","author":"L Gossec","year":"2005","unstructured":"Gossec\u00a0L et al (2005) Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis. Ann Rheum Dis 64(11):1563\u20131567","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR383","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/ard.2007.075309","volume":"67","author":"J Sieper","year":"2008","unstructured":"Sieper\u00a0J et al (2008) Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a\u00a012-week randomised, double-blind, controlled study. Ann Rheum Dis 67(3):323\u2013329","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR384","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/rheumatology\/keq078","volume":"49","author":"C Escalas","year":"2010","unstructured":"Escalas\u00a0C, Trijau\u00a0S, Dougados\u00a0M (2010) Evaluation of the treatment effect of NSAIDs\/TNF blockers according to different domains in ankylosing spondylitis: results of a\u00a0meta-analysis. Rheumatol (oxford) 49(7):1317\u20131325","journal-title":"Rheumatol (oxford)"},{"issue":"3","key":"670_CR385","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0300060516628704","volume":"44","author":"C Walker","year":"2016","unstructured":"Walker\u00a0C et al (2016) Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients. J\u00a0Int Med Res 44(3):483\u2013495","journal-title":"J Int Med Res"},{"issue":"1","key":"670_CR386","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12891-016-1275-5","volume":"17","author":"E Balazcs","year":"2016","unstructured":"Balazcs\u00a0E et\u00a0al (2016) A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis. Bmc Musculoskelet Disord 17(1):426","journal-title":"Bmc Musculoskelet Disord"},{"key":"670_CR387","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1471-2474-12-165","volume":"12","author":"PM Peloso","year":"2011","unstructured":"Peloso\u00a0PM et al (2011) Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis. Bmc Musculoskelet Disord 12:165","journal-title":"Bmc Musculoskelet Disord"},{"issue":"6","key":"670_CR388","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13075-014-0481-5","volume":"16","author":"M Dougados","year":"2014","unstructured":"Dougados\u00a0M et al (2014) Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study. Arthritis Res Ther 16(6):481","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"670_CR389","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/ard.2011.151563","volume":"70","author":"D van der Heijde","year":"2011","unstructured":"van der Heijde\u00a0D et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70(6):905\u2013908","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR390","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10067-005-0132-y","volume":"25","author":"J Zochling","year":"2006","unstructured":"Zochling\u00a0J et al (2006) Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis\u2014a population-based survey. Clin Rheumatol 25(6):794\u2013800","journal-title":"Clin Rheumatol"},{"issue":"6","key":"670_CR391","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders\u00a0A et\u00a0al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a\u00a0randomized clinical trial. Arthritis Rheum 52(6):1756\u20131765","journal-title":"Arthritis Rheum"},{"issue":"8","key":"670_CR392","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/annrheumdis-2015-207897","volume":"75","author":"J Sieper","year":"2016","unstructured":"Sieper\u00a0J et al (2016) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a\u00a0randomised multicentre trial (ENRADAS). Ann Rheum Dis 75(8):1438\u20131443","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR393","first-page":"CD008872","volume":"2011","author":"AN Colebatch","year":"2011","unstructured":"Colebatch\u00a0AN, Marks\u00a0JL, Edwards\u00a0CJ (2011) Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev 2011(11):CD8872","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"670_CR394","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/acr.22555","volume":"67","author":"LE Kristensen","year":"2015","unstructured":"Kristensen\u00a0LE et al (2015) Safety of Etoricoxib, Celecoxib, and nonselective Nonsteroidal antiinflammatory drugs in Ankylosing Spondylitis and other Spondyloarthritis patients: a Swedish national population-based cohort study. Arthritis Care Res (hoboken) 67(8):1137\u20131149","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"9549","key":"670_CR395","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","volume":"368","author":"CP Cannon","year":"2006","unstructured":"Cannon\u00a0CP et al (2006) Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a\u00a0randomised comparison. Lancet 368(9549):1771\u20131781","journal-title":"Lancet"},{"issue":"9435","key":"670_CR396","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(04)16894-3","volume":"364","author":"ME Farkouh","year":"2004","unstructured":"Farkouh\u00a0ME et\u00a0al (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 364(9435):675\u2013684","journal-title":"Lancet"},{"issue":"4","key":"670_CR397","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/art.23275","volume":"58","author":"IH Song","year":"2008","unstructured":"Song\u00a0IH et\u00a0al (2008) Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheum 58(4):929\u2013938","journal-title":"Arthritis Rheum"},{"key":"670_CR398","doi-asserted-by":"publisher","first-page":"j1909","DOI":"10.1136\/bmj.j1909","volume":"357","author":"M Bally","year":"2017","unstructured":"Bally\u00a0M et al (2017) Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 357:j1909","journal-title":"BMJ"},{"issue":"6","key":"670_CR399","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/2042098617690485","volume":"8","author":"A Fanelli","year":"2017","unstructured":"Fanelli\u00a0A et al (2017) Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Ther Adv Drug Saf 8(6):173\u2013182","journal-title":"Ther Adv Drug Saf"},{"key":"670_CR400","unstructured":"Bolten\u00a0W, Kr\u00fcger\u00a0K, Reiter\u00a0S (2009) Nichtsteroidale Antirheumatika, aktualisierte Empfehlungen zur Verordnung. Deutsche Gesellschaft f\u00fcr Rheumatologie. https:\/\/dgrh.de\/dam\/jcr:4a4ce23b-d97e-4395-b091-6368d9e8c7d4\/Nichtsteroidale_Antirheumatika_2009_final.pdf"},{"issue":"5","key":"670_CR401","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G Burmester","year":"2011","unstructured":"Burmester\u00a0G et al (2011) The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a\u00a0multidisciplinary European expert panel. Ann Rheum Dis 70(5):818\u2013822","journal-title":"Ann Rheum Dis"},{"key":"670_CR402","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (2008) Empfehlungen zur Therapie von degenerativen Gelenkerkrankungen. 35(Sonderheft 1)"},{"issue":"3","key":"670_CR403","first-page":"728","volume":"104","author":"FL Lanza","year":"2009","unstructured":"Lanza\u00a0FL et al (2009) Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 104(3):728\u2013738","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"670_CR404","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2710.2012.01373.x","volume":"38","author":"H Yokoyama","year":"2013","unstructured":"Yokoyama\u00a0H et al (2013) Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin. J\u00a0Clin Pharm Ther 38(1):12\u201315","journal-title":"J Clin Pharm Ther"},{"issue":"25","key":"670_CR405","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa003199","volume":"345","author":"F Catella-Lawson","year":"2001","unstructured":"Catella-Lawson\u00a0F et al (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N\u00a0Engl J Med 345(25):1809\u20131817","journal-title":"N Engl J Med"},{"issue":"1","key":"670_CR406","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang\u00a0X et al (2017) Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. Bmc Nephrol 18(1):256","journal-title":"Bmc Nephrol"},{"issue":"3","key":"670_CR407","doi-asserted-by":"publisher","first-page":"280 e1","DOI":"10.1016\/j.amjmed.2006.02.015","volume":"120","author":"K Gooch","year":"2007","unstructured":"Gooch\u00a0K et\u00a0al (2007) NSAID use and progression of chronic kidney disease. Am J Med 120(3):280 e1\u2013280 e7","journal-title":"Am J Med"},{"issue":"12","key":"670_CR408","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1365-4632.2010.04570.x","volume":"49","author":"KH Basavaraj","year":"2010","unstructured":"Basavaraj\u00a0KH et\u00a0al (2010) The role of drugs in the induction and\/or exacerbation of psoriasis. Int J Dermatol 49(12):1351\u20131361","journal-title":"Int J Dermatol"},{"issue":"3","key":"670_CR409","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"L Gossec","year":"2016","unstructured":"Gossec\u00a0L et\u00a0al (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499\u2013510","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR410","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/acr.22330","volume":"66","author":"F Canoui-Poitrine","year":"2014","unstructured":"Canoui-Poitrine\u00a0F et al (2014) Early tumor necrosis factor alpha antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a\u00a0prospective multicenter french cohort. Arthritis Care Res (hoboken) 66(9):1395\u20131402","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"11","key":"670_CR411","doi-asserted-by":"publisher","first-page":"e3060","DOI":"10.1097\/MD.0000000000003060","volume":"95","author":"C Chen","year":"2016","unstructured":"Chen\u00a0C et al (2016) Comparative effectiveness of biologic therapy regimens for Ankylosing Spondylitis: a systematic review and a\u00a0network Meta-analysis. Medicine (Baltimore) 95(11):e3060","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"670_CR412","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s40744-016-0038-y","volume":"3","author":"KA Betts","year":"2016","unstructured":"Betts\u00a0KA et al (2016) Network Meta-analysis and cost Per responder of tumor necrosis factor-alpha and Interleukin inhibitors in the treatment of active Ankylosing Spondylitis. Rheumatol Ther 3(2):323\u2013336","journal-title":"Rheumatol Ther"},{"issue":"6","key":"670_CR413","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","volume":"74","author":"J Callhoff","year":"2015","unstructured":"Callhoff\u00a0J et al (2015) Efficacy of TNFalpha blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a\u00a0meta-analysis. Ann Rheum Dis 74(6):1241\u20131248","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR414","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00590-012-1035-7","volume":"23","author":"ZH Li","year":"2013","unstructured":"Li\u00a0ZH et al (2013) Etanercept in the treatment of ankylosing spondylitis: a\u00a0meta-analysis of randomized, double-blind, placebo-controlled clinical trials, and the comparison of the Caucasian and Chinese population. Eur J Orthop Surg Traumatol 23(5):497\u2013506","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"2","key":"670_CR415","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/1756-185X.12245","volume":"17","author":"H Wang","year":"2014","unstructured":"Wang\u00a0H et al (2014) Randomized, placebo controlled and double-blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a\u00a0meta-analysis. Int J Rheum Dis 17(2):142\u2013148","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"670_CR416","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1159\/000447869","volume":"39","author":"Y Wang","year":"2016","unstructured":"Wang\u00a0Y et al (2016) Comparative efficacy and acceptability of anti-TNF-Alpha therapy in Ankylosing Spondylitis: a mixed-treatments comparison. Cell Physiol Biochem 39(5):1679\u20131694","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"670_CR417","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun\u00a0J et\u00a0al (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38(4):499\u2013505","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR418","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/ard.2005.041129","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling\u00a0J et\u00a0al (2006) Current evidence for the management of ankylosing spondylitis: a\u00a0systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 65(4):423\u2013432","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR419","doi-asserted-by":"publisher","first-page":"e000396","DOI":"10.1136\/rmdopen-2016-000396","volume":"3","author":"A Sepriano","year":"2017","unstructured":"Sepriano\u00a0A et al (2017) Efficacy and safety of biological and targeted-synthetic DMARDs: a\u00a0systematic literature review informing the 2016 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3(1):e396","journal-title":"RMD Open"},{"issue":"4","key":"670_CR420","first-page":"CD005468","volume":"2015","author":"LJ Maxwell","year":"2015","unstructured":"Maxwell\u00a0LJ et al (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 2015(4):CD5468","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"670_CR421","first-page":"935","volume":"34","author":"I Olivieri","year":"2016","unstructured":"Olivieri\u00a0I et al (2016) Efficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis. Clin Exp Rheumatol 34(5):935\u2013940","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"670_CR422","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/MAJ.0b013e3182926a23","volume":"346","author":"L Ren","year":"2013","unstructured":"Ren\u00a0L et\u00a0al (2013) Efficacy of antitumor necrosis factor(alpha) agents on patients with ankylosing spondylitis. Am J Med Sci 346(6):455\u2013461","journal-title":"Am J Med Sci"},{"issue":"9","key":"670_CR423","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/ard.2007.082529","volume":"67","author":"D van der Heijde","year":"2008","unstructured":"van der Heijde\u00a0D et\u00a0al (2008) Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis. Ann Rheum Dis 67(9):1218\u20131221","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR424","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/ard.2010.139261","volume":"70","author":"M Dougados","year":"2011","unstructured":"Dougados\u00a0M et al (2011) Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a\u00a0randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis 70(5):799\u2013804","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"670_CR425","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.23606","volume":"58","author":"H Haibel","year":"2008","unstructured":"Haibel\u00a0H et al (2008) Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a\u00a0twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 58(7):1981\u20131991","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR426","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/ard.2010.139667","volume":"70","author":"IH Song","year":"2011","unstructured":"Song\u00a0IH et al (2011) Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a\u00a048-week randomised controlled trial. Ann Rheum Dis 70(4):590\u2013596","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR427","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/art.24408","volume":"60","author":"N Barkham","year":"2009","unstructured":"Barkham\u00a0N et al (2009) Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 60(4):946\u2013954","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR428","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","volume":"72","author":"J Sieper","year":"2013","unstructured":"Sieper\u00a0J et al (2013) Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a\u00a0randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 72(6):815\u2013822","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR429","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20090","volume":"20","author":"M Corbett","year":"2016","unstructured":"Corbett\u00a0M et al (2016) Tumour necrosis factor-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a\u00a0systematic review and economic evaluation. Health Technol Assess 20(9):1\u2013334","journal-title":"Health Technol Assess"},{"issue":"12","key":"670_CR430","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1002\/art.38140","volume":"65","author":"A Ciurea","year":"2013","unstructured":"Ciurea\u00a0A et\u00a0al (2013) Tumor necrosis factor alpha inhibition in radiographic and Nonradiographic axial Spondyloarthritis: results from a\u00a0large observational cohort. Arthritis Rheum 65(12):3096\u20133106","journal-title":"Arthritis Rheum"},{"issue":"12","key":"670_CR431","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3899\/jrheum.150372","volume":"42","author":"J Corli","year":"2015","unstructured":"Corli\u00a0J et al (2015) Tumor necrosis factor-alpha inhibition in Ankylosing Spondylitis and Nonradiographic axial Spondyloarthritis: treatment response, drug survival, and patient outcome. J\u00a0Rheumatol 42(12):2376\u20132382","journal-title":"J Rheumatol"},{"issue":"10","key":"670_CR432","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/acr.20258","volume":"62","author":"LE Kristensen","year":"2010","unstructured":"Kristensen\u00a0LE et al (2010) Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register. Arthritis Care Res (hoboken) 62(10):1362\u20131369","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"3","key":"670_CR433","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/ar3369","volume":"13","author":"S Arends","year":"2011","unstructured":"Arends\u00a0S et al (2011) Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a\u00a0prospective longitudinal observational cohort study. Arthritis Res Ther 13(3):R94","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"670_CR434","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/ard.2010.147744","volume":"70","author":"N Vastesaeger","year":"2011","unstructured":"Vastesaeger\u00a0N et\u00a0al (2011) Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis 70(6):973\u2013981","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR435","doi-asserted-by":"publisher","first-page":"e000017","DOI":"10.1136\/rmdopen-2014-000017","volume":"1","author":"JR Maneiro","year":"2015","unstructured":"Maneiro\u00a0JR et al (2015) Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis. RMD Open 1(1):e17","journal-title":"RMD Open"},{"issue":"7","key":"670_CR436","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/art.21913","volume":"54","author":"D van der Heijde","year":"2006","unstructured":"van der Heijde\u00a0D et al (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a\u00a0multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54(7):2136\u20132146","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR437","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/ard.2007.087270","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde\u00a0D et al (2009) Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Ann Rheum Dis 68(6):922\u2013929","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR438","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1002\/art.11325","volume":"48","author":"JC Davis Jr.","year":"2003","unstructured":"Davis\u00a0JC Jr. et\u00a0al (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a\u00a0randomized, controlled trial. Arthritis Rheum 48(11):3230\u20133236","journal-title":"Arthritis Rheum"},{"issue":"11","key":"670_CR439","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1136\/ard.2004.035105","volume":"64","author":"JC Davis","year":"2005","unstructured":"Davis\u00a0JC et\u00a0al (2005) Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96\u00a0weeks. Ann Rheum Dis 64(11):1557\u20131562","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR440","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/ard.2007.078139","volume":"67","author":"JC Davis Jr.","year":"2008","unstructured":"Davis\u00a0JC Jr. et\u00a0al (2008) Efficacy and safety of up to 192\u00a0weeks of etanercept therapy in patients with ankylosing spondylitis. Ann Rheum Dis 67(3):346\u2013352","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"670_CR441","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard.2004.020875","volume":"63","author":"A Calin","year":"2004","unstructured":"Calin\u00a0A et\u00a0al (2004) Outcomes of a\u00a0multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 63(12):1594\u20131600","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR442","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3899\/jrheum.081033","volume":"36","author":"B Dijkmans","year":"2009","unstructured":"Dijkmans\u00a0B et\u00a0al (2009) Etanercept in the longterm treatment of patients with ankylosing spondylitis. J\u00a0Rheumatol 36(6):1256\u20131264","journal-title":"J Rheumatol"},{"issue":"2","key":"670_CR443","first-page":"238","volume":"28","author":"E Martin-Mola","year":"2010","unstructured":"Martin-Mola\u00a0E et al (2010) Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis. Clin Exp Rheumatol 28(2):238\u2013245","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"670_CR444","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1136\/ard.2006.056747","volume":"65","author":"D van der Heijde","year":"2006","unstructured":"van der Heijde\u00a0D et\u00a0al (2006) Etanercept 50\u202fmg once weekly is as effective as 25\u202fmg twice weekly in patients with ankylosing spondylitis. Ann Rheum Dis 65(12):1572\u20131577","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR445","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1136\/ard.2009.121533","volume":"69","author":"M Dougados","year":"2010","unstructured":"Dougados\u00a0M et al (2010) A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann Rheum Dis 69(8):1430\u20131435","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR446","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/rheumatology\/ker083","volume":"50","author":"F Navarro-Sarabia","year":"2011","unstructured":"Navarro-Sarabia\u00a0F et al (2011) High-dose etanercept in ankylosing spondylitis: results of a\u00a012-week randomized, double blind, controlled multicentre study (LOADET study). Rheumatol (oxford) 50(10):1828\u20131837","journal-title":"Rheumatol (oxford)"},{"issue":"6","key":"670_CR447","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/art.30223","volume":"63","author":"J Braun","year":"2011","unstructured":"Braun\u00a0J et al (2011) Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a\u00a0randomized, double-blind trial. Arthritis Rheum 63(6):1543\u20131551","journal-title":"Arthritis Rheum"},{"issue":"11","key":"670_CR448","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman\u00a0RD et al (2008) Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a\u00a0randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 58(11):3402\u20133412","journal-title":"Arthritis Rheum"},{"issue":"9313","key":"670_CR449","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun\u00a0J et\u00a0al (2002) Treatment of active ankylosing spondylitis with infliximab: a\u00a0randomised controlled multicentre trial. Lancet 359(9313):1187\u20131193","journal-title":"Lancet"},{"issue":"2","key":"670_CR450","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/ard.2004.025130","volume":"64","author":"J Braun","year":"2005","unstructured":"Braun\u00a0J et\u00a0al (2005) Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Ann Rheum Dis 64(2):229\u2013234","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR451","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/rheumatology\/keh584","volume":"44","author":"J Braun","year":"2005","unstructured":"Braun\u00a0J et al (2005) Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatol (oxford) 44(5):670\u2013676","journal-title":"Rheumatol (oxford)"},{"issue":"3","key":"670_CR452","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/ard.2007.075879","volume":"67","author":"J Braun","year":"2008","unstructured":"Braun\u00a0J et al (2008) Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Ann Rheum Dis 67(3):340\u2013345","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR453","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1093\/rheumatology\/ker194","volume":"50","author":"X Baraliakos","year":"2011","unstructured":"Baraliakos\u00a0X et al (2011) Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years\u2014early clinical response predicts long-term outcome. Rheumatol (oxford) 50(9):1690\u20131699","journal-title":"Rheumatol (oxford)"},{"issue":"2","key":"670_CR454","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"D van der Heijde","year":"2005","unstructured":"van der Heijde\u00a0D et al (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a\u00a0randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52(2):582\u2013591","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR455","first-page":"672","volume":"29","author":"F Heldmann","year":"2011","unstructured":"Heldmann\u00a0F et\u00a0al (2011) The European ankylosing spondylitis infliximab cohort (EASIC): a\u00a0European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol 29(4):672\u2013680","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"670_CR456","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/rheumatology\/keu132","volume":"53","author":"C Bao","year":"2014","unstructured":"Bao\u00a0C et al (2014) Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1\u2011year results of a\u00a0multicentre, randomized, double-blind, placebo-controlled phase III trial. Rheumatol (oxford) 53(9):1654\u20131663","journal-title":"Rheumatol (oxford)"},{"issue":"3","key":"670_CR457","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3899\/jrheum.170487","volume":"45","author":"A Deodhar","year":"2018","unstructured":"Deodhar\u00a0A et al (2018) Safety and efficacy of Golimumab administered intravenously in adults with Ankylosing Spondylitis: results through week 28 of the GO-ALIVE study. J\u00a0Rheumatol 45(3):341\u2013348","journal-title":"J Rheumatol"},{"issue":"8","key":"670_CR458","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/art.38721","volume":"66","author":"M Dougados","year":"2014","unstructured":"Dougados\u00a0M et al (2014) Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a\u00a0multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 66(8):2091\u20132102","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"670_CR459","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/annrheumdis-2012-202533","volume":"73","author":"F Huang","year":"2014","unstructured":"Huang\u00a0F et\u00a0al (2014) Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a\u00a0randomised, controlled trial. Ann Rheum Dis 73(3):587\u2013594","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR460","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","volume":"73","author":"R Landewe","year":"2014","unstructured":"Landewe\u00a0R et al (2014) Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a\u00a0double-blind randomised placebo-controlled Phase 3 study. Ann Rheum Dis 73(1):39\u201347","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR461","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1136\/annrheumdis-2012-203091","volume":"72","author":"W Park","year":"2013","unstructured":"Park\u00a0W et al (2013) A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. Ann Rheum Dis 72(10):1605\u20131612","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR462","first-page":"380","volume":"34","author":"JD Cohen","year":"2007","unstructured":"Cohen\u00a0JD et al (2007) Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a\u00a0case series. J\u00a0Rheumatol 34(2):380\u2013385","journal-title":"J Rheumatol"},{"issue":"6","key":"670_CR463","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/art.22887","volume":"57","author":"JC Davis Jr.","year":"2007","unstructured":"Davis\u00a0JC Jr. et al (2007) Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a\u00a0randomized controlled study. Arthritis Rheum 57(6):1050\u20131057","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR464","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kem069","volume":"46","author":"J Braun","year":"2007","unstructured":"Braun\u00a0J et al (2007) Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50\u202fmg once-weekly and 25\u202fmg twice-weekly. Rheumatol (oxford) 46(6):999\u20131004","journal-title":"Rheumatol (oxford)"},{"issue":"4","key":"670_CR465","first-page":"662","volume":"35","author":"A Boonen","year":"2008","unstructured":"Boonen\u00a0A et al (2008) Rapid and sustained improvement in health-related quality of life and utility for 72\u00a0weeks in patients with ankylosing spondylitis receiving etanercept. J\u00a0Rheumatol 35(4):662\u2013667","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR466","first-page":"624","volume":"29","author":"M Kimel","year":"2011","unstructured":"Kimel\u00a0M et al (2011) Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis. Clin Exp Rheumatol 29(4):624\u2013632","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"670_CR467","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/art.24865","volume":"61","author":"J Braun","year":"2009","unstructured":"Braun\u00a0J et\u00a0al (2009) Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab. Arthritis Rheum 61(8):1032\u20131036","journal-title":"Arthritis Rheum"},{"issue":"3","key":"670_CR468","first-page":"401","volume":"26","author":"C Gonnet-Gracia","year":"2008","unstructured":"Gonnet-Gracia\u00a0C et al (2008) Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers. Clin Exp Rheumatol 26(3):401\u2013407","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"670_CR469","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3899\/jrheum.091043","volume":"37","author":"WP Maksymowych","year":"2010","unstructured":"Maksymowych\u00a0WP et al (2010) Low-dose infliximab (3\u202fmg\/kg) significantly reduces spinal inflammation on magnetic resonance imaging in patients with ankylosing spondylitis: a\u00a0randomized placebo-controlled study. J\u00a0Rheumatol 37(8):1728\u20131734","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR470","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.23471","volume":"58","author":"D van der Heijde","year":"2008","unstructured":"van der Heijde\u00a0D et\u00a0al (2008) Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58(5):1324\u20131331","journal-title":"Arthritis Rheum"},{"issue":"9","key":"670_CR471","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/rheumatology\/kem166","volume":"46","author":"X Baraliakos","year":"2007","unstructured":"Baraliakos\u00a0X et al (2007) Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab. Rheumatol (oxford) 46(9):1450\u20131453","journal-title":"Rheumatol (oxford)"},{"issue":"10","key":"670_CR472","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon\u00a0N et\u00a0al (2013) The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645\u20132654","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR473","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jbspin.2015.09.006","volume":"83","author":"TJ Kim","year":"2016","unstructured":"Kim\u00a0TJ et\u00a0al (2016) Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data. Joint Bone Spine 83(5):569\u2013572","journal-title":"Joint Bone Spine"},{"issue":"7","key":"670_CR474","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/acr.23097","volume":"69","author":"F Maas","year":"2017","unstructured":"Maas\u00a0F et\u00a0al (2017) Reduction in spinal radiographic progression in Ankylosing Spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors. Arthritis Care Res (hoboken) 69(7):1011\u20131019","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"1","key":"670_CR475","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"C Molnar","year":"2018","unstructured":"Molnar\u00a0C et\u00a0al (2018) TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77(1):63\u201369","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"670_CR476","doi-asserted-by":"publisher","first-page":"e0168958","DOI":"10.1371\/journal.pone.0168958","volume":"11","author":"JW Park","year":"2016","unstructured":"Park\u00a0JW et\u00a0al (2016) Impact of dose tapering of tumor necrosis factor inhibitor on radiographic progression in Ankylosing Spondylitis. PLoS ONE 11(12):e168958","journal-title":"PLoS ONE"},{"issue":"2","key":"670_CR477","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/ard.2007.084426","volume":"68","author":"S Visvanathan","year":"2009","unstructured":"Visvanathan\u00a0S et\u00a0al (2009) Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 68(2):175\u2013182","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR478","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/acr.22519","volume":"67","author":"S Siu","year":"2015","unstructured":"Siu\u00a0S et al (2015) Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res (hoboken) 67(6):754\u2013764","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"4","key":"670_CR479","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.22097","volume":"55","author":"D van der Heijde","year":"2006","unstructured":"van der Heijde\u00a0D et al (2006) Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a\u00a0randomized, placebo-controlled trial. Arthritis Rheum 55(4):569\u2013574","journal-title":"Arthritis Rheum"},{"issue":"11","key":"670_CR480","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1136\/ard.2009.121327","volume":"69","author":"N Barkham","year":"2010","unstructured":"Barkham\u00a0N et al (2010) Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis. Ann Rheum Dis 69(11):1926\u20131928","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR481","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/rheumatology\/ken010","volume":"47","author":"AC Keat","year":"2008","unstructured":"Keat\u00a0AC et\u00a0al (2008) Influence of biologic therapy on return to work in people with work disability due to ankylosing spondylitis. Rheumatol (oxford) 47(4):481\u2013483","journal-title":"Rheumatol (oxford)"},{"issue":"2","key":"670_CR482","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/rheumatology\/ker169","volume":"51","author":"LE Kristensen","year":"2012","unstructured":"Kristensen\u00a0LE et al (2012) Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a\u00a0population-based cohort study. Rheumatology (Oxford) 51(2):243\u2013249","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"670_CR483","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3899\/jrheum.090242","volume":"37","author":"WP Maksymowych","year":"2010","unstructured":"Maksymowych\u00a0WP et al (2010) Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J\u00a0Rheumatol 37(2):385\u2013392","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR484","first-page":"716","volume":"56","author":"JK Wallman","year":"2017","unstructured":"Wallman\u00a0JK et al (2017) Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a\u00a0population-based regional cohort study from southern Sweden. Rheumatology (Oxford) 56(5):716\u2013724","journal-title":"Rheumatology (Oxford)"},{"issue":"9906","key":"670_CR485","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten\u00a0D et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a\u00a0randomised, double-blind, placebo-controlled trial. Lancet 382(9906):1705\u20131713","journal-title":"Lancet"},{"issue":"26","key":"670_CR486","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten\u00a0D et al (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N\u00a0Engl J Med 373(26):2534\u20132548","journal-title":"N Engl J Med"},{"issue":"3","key":"670_CR487","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/annrheumdis-2016-210023","volume":"76","author":"J Sieper","year":"2017","unstructured":"Sieper\u00a0J et al (2017) Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study. Ann Rheum Dis 76(3):571\u2013592","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR488","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","volume":"19","author":"K Pavelka","year":"2017","unstructured":"Pavelka\u00a0K et al (2017) Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a\u00a0randomized, double-blind phase 3 study, MEASURE 3. Arthritis Res Ther 19(1):285","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"670_CR489","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1002\/art.39805","volume":"68","author":"AA Deodhar","year":"2016","unstructured":"Deodhar\u00a0AA et al (2016) Effect of Secukinumab on patient-reported outcomes in patients with active Ankylosing Spondylitis: a phase III randomized trial (MEASURE 1). Arthritis Rheumatol 68(12):2901\u20132910","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"670_CR490","first-page":"260","volume":"37","author":"A Deodhar","year":"2019","unstructured":"Deodhar\u00a0A et al (2019) Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C\u2011reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2\u2011year data from the MEASURE 2 study. Clin Exp Rheumatol 37(2):260\u2013269","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"670_CR491","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/annrheumdis-2015-207544","volume":"75","author":"X Baraliakos","year":"2016","unstructured":"Baraliakos\u00a0X et al (2016) Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study. Ann Rheum Dis 75(2):408\u2013412","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR492","first-page":"50","volume":"36","author":"X Baraliakos","year":"2018","unstructured":"Baraliakos\u00a0X et al (2018) Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3\u2011year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. Clin Exp Rheumatol 36(1):50\u201355","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"670_CR493","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","volume":"76","author":"J Braun","year":"2017","unstructured":"Braun\u00a0J et al (2017) Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2\u2011year results from the randomised phase III MEASURE 1 study. Ann Rheum Dis 76(6):1070\u20131077","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR494","doi-asserted-by":"publisher","first-page":"e000592","DOI":"10.1136\/rmdopen-2017-000592","volume":"3","author":"H Marzo-Ortega","year":"2017","unstructured":"Marzo-Ortega\u00a0H et al (2017) Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3\u2011year results from the phase III trial, MEASURE 2. RMD Open 3(2):e592","journal-title":"RMD Open"},{"issue":"5","key":"670_CR495","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/art.27383","volume":"62","author":"IH Song","year":"2010","unstructured":"Song\u00a0IH et al (2010) Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a\u00a0twenty-four-week clinical trial. Arthritis Rheum 62(5):1290\u20131297","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR496","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1136\/ard.2010.145946","volume":"70","author":"IH Song","year":"2011","unstructured":"Song\u00a0IH et al (2011) Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study. Ann Rheum Dis 70(6):1108\u20131110","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"670_CR497","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/annrheumdis-2013-204963","volume":"74","author":"J Sieper","year":"2015","unstructured":"Sieper\u00a0J et al (2015) Sarilumab for the treatment of ankylosing spondylitis: results of a\u00a0Phase II, randomised, double-blind, placebo-controlled study (ALIGN). Ann Rheum Dis 74(6):1051\u20131057","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"670_CR498","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/annrheumdis-2013-203559","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper\u00a0J et al (2014) Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Ann Rheum Dis 73(19):95\u2013100","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR499","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","volume":"73","author":"D Poddubnyy","year":"2014","unstructured":"Poddubnyy\u00a0D et al (2014) Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a\u00a028-week, prospective, open-label, proof-of-concept study (TOPAS). Ann Rheum Dis 73(5):817\u2013823","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"670_CR500","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.40728","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar\u00a0A et al (2019) Three Multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of Ustekinumab in axial Spondyloarthritis. Arthritis Rheumatol 71(2):258\u2013270","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"670_CR501","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/art.23333","volume":"59","author":"MS Heiberg","year":"2008","unstructured":"Heiberg\u00a0MS et al (2008) The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a\u00a0longitudinal, observational, multicenter study. Arthritis Rheum 59(2):234\u2013240","journal-title":"Arthritis Rheum"},{"issue":"7","key":"670_CR502","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1136\/annrheumdis-2012-201933","volume":"72","author":"B Glintborg","year":"2013","unstructured":"Glintborg\u00a0B et\u00a0al (2013) Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor alpha inhibitor therapy: results from the Danish nationwide DANBIO registry. Ann Rheum Dis 72(7):1149\u20131155","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR503","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/annrheumdis-2013-205133","volume":"75","author":"A Ciurea","year":"2016","unstructured":"Ciurea\u00a0A et\u00a0al (2016) Impaired response to treatment with tumour necrosis factor alpha inhibitors in smokers with axial spondyloarthritis. Ann Rheum Dis 75(3):532\u2013539","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR504","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/rheumatology\/kev392","volume":"55","author":"B Glintborg","year":"2016","unstructured":"Glintborg\u00a0B et al (2016) Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Rheumatol (oxford) 55(4):659\u2013668","journal-title":"Rheumatol (oxford)"},{"issue":"1","key":"670_CR505","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-017-1372-3","volume":"19","author":"R Micheroli","year":"2017","unstructured":"Micheroli\u00a0R et\u00a0al (2017) Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis Res Ther 19(1):164","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"670_CR506","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/art.23167","volume":"58","author":"M Breban","year":"2008","unstructured":"Breban\u00a0M et al (2008) Maintenance of infliximab treatment in ankylosing spondylitis: results of a\u00a0one-year randomized controlled trial comparing systematic versus on-demand treatment. Arthritis Rheum 58(1):88\u201397","journal-title":"Arthritis Rheum"},{"issue":"11","key":"670_CR507","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/ard.2004.022582","volume":"64","author":"H Marzo-Ortega","year":"2005","unstructured":"Marzo-Ortega\u00a0H et al (2005) Infliximab in combination with methotrexate in active ankylosing spondylitis: a\u00a0clinical and imaging study. Ann Rheum Dis 64(11):1568\u20131575","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR508","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/rheumatology\/ken207","volume":"47","author":"EK Li","year":"2008","unstructured":"Li\u00a0EK et al (2008) Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a\u00a0clinical and magnetic resonance imaging correlation. Rheumatol (oxford) 47(9):1358\u20131363","journal-title":"Rheumatol (oxford)"},{"issue":"3","key":"670_CR509","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jbspin.2006.08.005","volume":"74","author":"VC Perez-Guijo","year":"2007","unstructured":"Perez-Guijo\u00a0VC et al (2007) Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis. Joint Bone Spine 74(3):254\u2013258","journal-title":"Joint Bone Spine"},{"issue":"25","key":"670_CR510","doi-asserted-by":"publisher","first-page":"e7145","DOI":"10.1097\/MD.0000000000007145","volume":"96","author":"Z Ma","year":"2017","unstructured":"Ma\u00a0Z et al (2017) Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: a meta-analysis. Medicine (Baltimore) 96(25):e7145","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"670_CR511","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-0029-1214673","volume":"63","author":"R Diel","year":"2009","unstructured":"Diel\u00a0R et al (2009) Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases. Pneumologie 63(6):329\u2013334","journal-title":"Pneumologie"},{"issue":"10","key":"670_CR512","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1136\/ard.2008.098822","volume":"69","author":"A Fouque-Aubert","year":"2010","unstructured":"Fouque-Aubert\u00a0A et al (2010) Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a\u00a0systematic review and meta-analysis of randomised placebo-controlled trials. Ann Rheum Dis 69(10):1756\u20131761","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR513","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3892\/etm.2017.5003","volume":"14","author":"Z Xu","year":"2017","unstructured":"Xu\u00a0Z et al (2017) Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: a meta-analysis of randomized controlled trials. Exp Ther Med 14(4):3491\u20133500","journal-title":"Exp Ther Med"},{"issue":"11","key":"670_CR514","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1136\/ard.2010.149419","volume":"70","author":"X Mariette","year":"2011","unstructured":"Mariette\u00a0X et al (2011) Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a\u00a0systematic review and meta-analysis. Ann Rheum Dis 70(11):1895\u20131904","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR515","doi-asserted-by":"publisher","first-page":"R439","DOI":"10.1186\/ar1693","volume":"7","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos\u00a0X et al (2005) Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. Arthritis Res Ther 7(3):R439\u2013R444","journal-title":"Arthritis Res Ther"},{"issue":"10142","key":"670_CR516","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0140-6736(18)31362-X","volume":"392","author":"R Landewe","year":"2018","unstructured":"Landewe\u00a0R et al (2018) Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a\u00a0multicentre, randomised, double-blind study. Lancet 392(10142):134\u2013144","journal-title":"Lancet"},{"issue":"1","key":"670_CR517","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/annrheumdis-2013-203460","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper\u00a0J et al (2014) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a\u00a06-month, randomised, open-label follow-up study, INFAST Part 2. Ann Rheum Dis 73(1):108\u2013113","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR518","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/rheumatology\/kew269","volume":"55","author":"W Fong","year":"2016","unstructured":"Fong\u00a0W et\u00a0al (2016) The effectiveness of a\u00a0real life dose reduction strategy for tumour necrosis factor inhibitors in ankylosing spondylitis and psoriatic arthritis. Rheumatol (oxford) 55(10):1837\u20131842","journal-title":"Rheumatol (oxford)"},{"issue":"6","key":"670_CR519","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3899\/jrheum.091042","volume":"37","author":"RD Inman","year":"2010","unstructured":"Inman\u00a0RD, Maksymowych\u00a0WP (2010) A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis. J\u00a0Rheumatol 37(6):1203\u20131210","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR520","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.24275","volume":"61","author":"R Krzysiek","year":"2009","unstructured":"Krzysiek\u00a0R et\u00a0al (2009) Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a\u00a0randomized control study. Arthritis Rheum 61(5):569\u2013576","journal-title":"Arthritis Rheum"},{"issue":"5","key":"670_CR521","first-page":"661","volume":"28","author":"S Arends","year":"2010","unstructured":"Arends\u00a0S et al (2010) The formation of autoantibodies and antibodies to TNF-alpha blocking agents in relation to clinical response in patients with ankylosing spondylitis. Clin Exp Rheumatol 28(5):661\u2013668","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"670_CR522","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1136\/ard.2007.072397","volume":"66","author":"MK de Vries","year":"2007","unstructured":"de Vries\u00a0MK et al (2007) Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation. Ann Rheum Dis 66(9):1252\u20131254","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR523","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/ard.2008.089979","volume":"68","author":"MK de Vries","year":"2009","unstructured":"de Vries\u00a0MK et\u00a0al (2009) Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis. Ann Rheum Dis 68(4):531\u2013535","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR524","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/ard.2010.131797","volume":"70","author":"E Lie","year":"2011","unstructured":"Lie\u00a0E et al (2011) Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register. Ann Rheum Dis 70(1):157\u2013163","journal-title":"Ann Rheum Dis"},{"key":"670_CR525","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13075-016-0969-2","volume":"18","author":"A Ciurea","year":"2016","unstructured":"Ciurea\u00a0A et\u00a0al (2016) Does the reason for discontinuation of a\u00a0first TNF inhibitor influence the effectiveness of a\u00a0second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort. Arthritis Res Ther 18:71","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"670_CR526","doi-asserted-by":"publisher","first-page":"e000524","DOI":"10.1136\/rmdopen-2017-000524","volume":"3","author":"V Navarro-Compan","year":"2017","unstructured":"Navarro-Compan\u00a0V et al (2017) Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a\u00a0systematic literature review. RMD Open 3(2):e524","journal-title":"RMD Open"},{"issue":"3","key":"670_CR527","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.semarthrit.2017.04.005","volume":"47","author":"A Deodhar","year":"2017","unstructured":"Deodhar\u00a0A, Yu\u00a0D (2017) Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. Semin Arthritis Rheum 47(3):343\u2013350","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"670_CR528","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1002\/art.39772","volume":"68","author":"A Sepriano","year":"2016","unstructured":"Sepriano\u00a0A et al (2016) Effect of Comedication with conventional synthetic disease-modifying Antirheumatic drugs on retention of tumor necrosis factor inhibitors in patients with Spondyloarthritis: a prospective cohort study. Arthritis Rheumatol 68(11):2671\u20132679","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"670_CR529","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/art.39691","volume":"68","author":"MJ Nissen","year":"2016","unstructured":"Nissen\u00a0MJ et al (2016) The effect of Comedication with a\u00a0conventional synthetic disease-modifying Antirheumatic drug on drug retention and clinical effectiveness of anti-tumor necrosis factor therapy in patients with axial Spondyloarthritis. Arthritis Rheumatol 68(9):2141\u20132150","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"670_CR530","first-page":"CD004800","volume":"2005","author":"J Chen","year":"2005","unstructured":"Chen\u00a0J, Liu\u00a0C (2005) Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2005(2):CD4800","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"670_CR531","first-page":"CD004800","volume":"2014","author":"J Chen","year":"2014","unstructured":"Chen\u00a0J, Lin\u00a0S, Liu\u00a0C (2014) Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2014(11):CD4800","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"670_CR532","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/rheumatology\/ket450","volume":"53","author":"KM Fagerli","year":"2014","unstructured":"Fagerli\u00a0KM et al (2014) Is there a\u00a0role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study. Rheumatol (oxford) 53(6):1087\u20131094","journal-title":"Rheumatol (oxford)"},{"issue":"7","key":"670_CR533","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s10067-006-0460-6","volume":"26","author":"H Genc","year":"2007","unstructured":"Genc\u00a0H et\u00a0al (2007) The effects of sulfasalazine treatment on enthesal abnormalities of inflammatory rheumatic diseases. Clin Rheumatol 26(7):1104\u20131110","journal-title":"Clin Rheumatol"},{"issue":"9","key":"670_CR534","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1136\/ard.2006.052878","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun\u00a0J et\u00a0al (2006) Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a\u00a0multicentre randomised controlled trial. Ann Rheum Dis 65(9):1147\u20131153","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR535","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/1756-185X.13124","volume":"21","author":"S Khanna Sharma","year":"2018","unstructured":"Khanna Sharma\u00a0S et\u00a0al (2018) A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis. Int J Rheum Dis 21(1):308\u2013314","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"670_CR536","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3892\/etm.2014.1974","volume":"8","author":"YF Liu","year":"2014","unstructured":"Liu\u00a0YF et al (2014) Etanercept in the treatment of ankylosing spondylitis: a systematic review and meta-analysis. Exp Ther Med 8(5):1585\u20131592","journal-title":"Exp Ther Med"},{"issue":"6","key":"670_CR537","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-012-2571-5","volume":"33","author":"X Deng","year":"2013","unstructured":"Deng\u00a0X et\u00a0al (2013) Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept. Rheumatol Int 33(6):1409\u20131413","journal-title":"Rheumatol Int"},{"issue":"4","key":"670_CR538","first-page":"CD004524","volume":"2006","author":"J Chen","year":"2006","unstructured":"Chen\u00a0J, Liu\u00a0C, Lin\u00a0J (2006) Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 2006(4):CD4524","journal-title":"Cochrane Database Syst Rev"},{"key":"670_CR539","first-page":"2","volume":"CD004524","author":"J Chen","year":"2013","unstructured":"Chen\u00a0J et\u00a0al (2013) Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev CD004524:2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"670_CR540","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/annrheumdis-2012-203055","volume":"73","author":"H Haibel","year":"2014","unstructured":"Haibel\u00a0H et al (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a\u00a0double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73(1):243\u2013246","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"670_CR541","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.10139","volume":"46","author":"WP Maksymowych","year":"2002","unstructured":"Maksymowych\u00a0WP et al (2002) A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60\u202fmg versus 10\u202fmg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46(3):766\u2013773","journal-title":"Arthritis Rheum"},{"issue":"8","key":"670_CR542","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/rheumatology\/keg256","volume":"42","author":"H Haibel","year":"2003","unstructured":"Haibel\u00a0H et\u00a0al (2003) Treatment of active ankylosing spondylitis with pamidronate. Rheumatol (oxford) 42(8):1018\u20131020","journal-title":"Rheumatol (oxford)"},{"issue":"2","key":"670_CR543","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/ard.2004.022871","volume":"64","author":"AP Cairns","year":"2005","unstructured":"Cairns\u00a0AP et\u00a0al (2005) An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Ann Rheum Dis 64(2):338\u2013339","journal-title":"Ann Rheum Dis"},{"key":"670_CR544","first-page":"193","volume":"55","author":"AN Malaviya","year":"2007","unstructured":"Malaviya\u00a0AN et al (2007) A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a\u00a0combination of disease modifying drugs sulfasalazine and methotrexate. J\u00a0Assoc Physicians India 55:193\u2013197","journal-title":"J Assoc Physicians India"},{"issue":"11","key":"670_CR545","first-page":"883","volume":"51","author":"G Santra","year":"2010","unstructured":"Santra\u00a0G et\u00a0al (2010) Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial. Singapore Med\u00a0J 51(11):883\u2013887","journal-title":"Singapore Med J"},{"issue":"3","key":"670_CR546","first-page":"445","volume":"35","author":"L Coates","year":"2017","unstructured":"Coates\u00a0L et al (2017) Clinical efficacy of oral alendronate in ankylosing spondylitis: a\u00a0randomised placebo-controlled trial. Clin Exp Rheumatol 35(3):445\u2013451","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"670_CR547","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10067-008-1029-3","volume":"28","author":"SM Chatfield","year":"2009","unstructured":"Chatfield\u00a0SM et al (2009) Complementary and alternative medicines in ankylosing spondylitis: a\u00a0cross-sectional study. Clin Rheumatol 28(2):213\u2013217","journal-title":"Clin Rheumatol"},{"key":"670_CR548","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2474-9-4","volume":"9","author":"S Brophy","year":"2008","unstructured":"Brophy\u00a0S et al (2008) Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathy. Bmc Musculoskelet Disord 9:4","journal-title":"Bmc Musculoskelet Disord"},{"issue":"10","key":"670_CR549","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3899\/jrheum.100193","volume":"37","author":"K Jenks","year":"2010","unstructured":"Jenks\u00a0K et\u00a0al (2010) Probiotic therapy for the treatment of spondyloarthritis: a\u00a0randomized controlled trial. J\u00a0Rheumatol 37(10):2118\u20132125","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR550","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"C Gotestam Skorpen","year":"2016","unstructured":"Gotestam Skorpen\u00a0C et\u00a0al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795\u2013810","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"670_CR551","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","volume":"55","author":"J Flint","year":"2016","unstructured":"Flint\u00a0J et al (2016) BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatol (oxford) 55(9):1693\u20131697","journal-title":"Rheumatol (oxford)"},{"issue":"10","key":"670_CR552","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1136\/ard.2009.127423","volume":"69","author":"PM Villiger","year":"2010","unstructured":"Villiger\u00a0PM et\u00a0al (2010) Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 69(10):1842\u20131844","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"670_CR553","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/ard.2010.140822","volume":"70","author":"SM Verstappen","year":"2011","unstructured":"Verstappen\u00a0SM et al (2011) Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis 70(5):823\u2013826","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"670_CR554","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/annrheumdis-2015-207992","volume":"75","author":"GL Jakobsson","year":"2015","unstructured":"Jakobsson\u00a0GL et\u00a0al (2016) Pregnancy outcomes in patients with ankylosing spondylitis: a\u00a0nationwide register study. Ann Rheum Dis 75(10):1838\u20131842","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR555","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13075-017-1269-1","volume":"19","author":"S van den Brandt","year":"2017","unstructured":"van den Brandt\u00a0S et\u00a0al (2017) Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther 19(1):64","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"670_CR556","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3899\/jrheum.130996","volume":"41","author":"D Mahendira","year":"2014","unstructured":"Mahendira\u00a0D et\u00a0al (2014) Analysis of the effect of the oral contraceptive pill on clinical outcomes in women with ankylosing spondylitis. J\u00a0Rheumatol 41(7):1344\u20131348","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR557","first-page":"642","volume":"29","author":"Z Huang","year":"2011","unstructured":"Huang\u00a0Z et al (2011) Efficacy and safety of ultrasound-guided local injections of etanercept into entheses of ankylosing spondylitis patients with refractory Achilles enthesitis. Clin Exp Rheumatol 29(4):642\u2013649","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"670_CR558","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/rheumatology\/35.8.767","volume":"35","author":"Y Maugars","year":"1996","unstructured":"Maugars\u00a0Y et al (1996) Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a\u00a0double-blind study. Br J Rheumatol 35(8):767\u2013770","journal-title":"Br J Rheumatol"},{"issue":"1","key":"670_CR559","first-page":"88","volume":"17","author":"R Luukkainen","year":"1999","unstructured":"Luukkainen\u00a0R et\u00a0al (1999) Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Clin Exp Rheumatol 17(1):88\u201390","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"670_CR560","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00296-014-2959-5","volume":"34","author":"Y Zheng","year":"2014","unstructured":"Zheng\u00a0Y et al (2014) Tomography-guided palisade sacroiliac joint radiofrequency neurotomy versus celecoxib for ankylosing spondylitis: a\u00a0open-label, randomized, and controlled trial. Rheumatol Int 34(9):1195\u20131202","journal-title":"Rheumatol Int"},{"issue":"4","key":"670_CR561","first-page":"659","volume":"23","author":"J Braun","year":"1996","unstructured":"Braun\u00a0J et\u00a0al (1996) Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. J\u00a0Rheumatol 23(4):659\u2013664","journal-title":"J Rheumatol"},{"issue":"1","key":"670_CR562","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/kep174","volume":"49","author":"B Vander Cruyssen","year":"2010","unstructured":"Vander Cruyssen\u00a0B et\u00a0al (2010) Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatol (oxford) 49(1):73\u201381","journal-title":"Rheumatol (oxford)"},{"issue":"11","key":"670_CR563","doi-asserted-by":"publisher","first-page":"e0187594","DOI":"10.1371\/journal.pone.0187594","volume":"12","author":"MC Lu","year":"2017","unstructured":"Lu\u00a0MC et al (2017) Incident osteoarthritis and osteoarthritis-related joint replacement surgery in patients with ankylosing spondylitis: a secondary cohort analysis of a\u00a0nationwide, population-based health claims database. PLoS ONE 12(11):e187594","journal-title":"PLoS ONE"},{"issue":"6","key":"670_CR564","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.arth.2007.07.014","volume":"23","author":"S Bhan","year":"2008","unstructured":"Bhan\u00a0S, Eachempati\u00a0KK, Malhotra\u00a0R (2008) Primary cementless total hip arthroplasty for bony ankylosis in patients with ankylosing spondylitis. J\u00a0Arthroplasty 23(6):859\u2013866","journal-title":"J. Arthroplasty"},{"issue":"1","key":"670_CR565","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00586-009-1104-8","volume":"19","author":"T Kiaer","year":"2010","unstructured":"Kiaer\u00a0T, Gehrchen\u00a0M (2010) Transpedicular closed wedge osteotomy in ankylosing spondylitis: results of surgical treatment and prospective outcome analysis. Eur Spine\u00a0J 19(1):57\u201364","journal-title":"Eur Spine J"},{"issue":"1","key":"670_CR566","doi-asserted-by":"publisher","first-page":"e000397","DOI":"10.1136\/rmdopen-2016-000397","volume":"3","author":"A Regel","year":"2017","unstructured":"Regel\u00a0A et al (2017) Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a\u00a0systematic literature review informing the 2016 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. RMD Open 3(1):e397","journal-title":"RMD Open"},{"issue":"1","key":"670_CR567","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/FOC\/2008\/24\/1\/E7","volume":"24","author":"RR Pigge","year":"2008","unstructured":"Pigge\u00a0RR et\u00a0al (2008) Effectiveness of preoperative planning in the restoration of balance and view in ankylosing spondylitis. Neurosurg Focus 24(1):E7","journal-title":"Neurosurg Focus"},{"issue":"3","key":"670_CR568","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00586-010-1628-y","volume":"20","author":"F Anwar","year":"2011","unstructured":"Anwar\u00a0F et al (2011) Delayed presentation and diagnosis of cervical spine injuries in long-standing ankylosing spondylitis. Eur Spine\u00a0J 20(3):403\u2013407","journal-title":"Eur Spine J"},{"issue":"1","key":"670_CR569","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/FOC\/2008\/24\/1\/E9","volume":"24","author":"DJ Hoh","year":"2008","unstructured":"Hoh\u00a0DJ, Khoueir\u00a0P, Wang\u00a0MY (2008) Management of cervical deformity in ankylosing spondylitis. Neurosurg Focus 24(1):E9","journal-title":"Neurosurg Focus"},{"key":"670_CR570","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2474-10-96","volume":"10","author":"G Sapkas","year":"2009","unstructured":"Sapkas\u00a0G et\u00a0al (2009) Surgical outcome after spinal fractures in patients with ankylosing spondylitis. Bmc Musculoskelet Disord 10:96","journal-title":"Bmc Musculoskelet Disord"},{"issue":"26","key":"670_CR571","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1097\/BRS.0b013e31815cddfc","volume":"32","author":"P Thumbikat","year":"2007","unstructured":"Thumbikat\u00a0P et al (2007) Spinal cord injury in patients with ankylosing spondylitis: a\u00a010-year review. Spine (phila Pa 1976) 32(26):2989\u20132995","journal-title":"Spine (phila Pa 1976)"},{"issue":"2","key":"670_CR572","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/BSD.0b013e3181679bcb","volume":"22","author":"PG Whang","year":"2009","unstructured":"Whang\u00a0PG et\u00a0al (2009) The management of spinal injuries in patients with ankylosing spondylitis or diffuse idiopathic skeletal hyperostosis: a\u00a0comparison of treatment methods and clinical outcomes. J\u00a0Spinal Disord Tech 22(2):77\u201385","journal-title":"J Spinal Disord Tech"},{"key":"670_CR573","unstructured":"Kr\u00fcger\u00a0KAK, Rehart\u00a0S, Scholz\u00a0R, Kommission Pharmakotherapie der DGRh (2014) Empfehlungen der Deutschen Gesellschaft f\u00fcr Rheumatologie zur perioperativen Vorgehensweise unter Therapie mit DMARDs und Biologika bei entz\u00fcndlich-rheumatischen Erkrankungen. Deutsche Gesellschaft f\u00fcr Rheumatologie. https:\/\/dgrh.de\/dam\/jcr:e8ac6b95-3a2f-4113-ab59-da18f1cb7cf4\/empfehlungen_periop.pdf"},{"key":"670_CR574","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5152\/tjr.2011.020","volume":"26","author":"F Ayhan","year":"2011","unstructured":"Ayhan\u00a0F, Gecene\u00a0M, G\u00fcnd\u00fcz\u00a0R (2011) Long-term effects of comprehensive inpatient rehabilitation on function and disease activity in patients with chronic rheumatoid arthritis and Ankylosing Spondylitis. Turk J Rheumatol 26:135\u2013142","journal-title":"Turk J Rheumatol"},{"issue":"6","key":"670_CR575","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2340\/16501977-0804","volume":"43","author":"YA Staalesen Strumse","year":"2011","unstructured":"Staalesen Strumse\u00a0YA et al (2011) Efficacy of rehabilitation for patients with ankylosing spondylitis: comparison of a\u00a0four-week rehabilitation programme in a\u00a0Mediterranean and a\u00a0Norwegian setting. J\u00a0Rehabil Med 43(6):534\u2013542","journal-title":"J Rehabil Med"},{"issue":"7","key":"670_CR576","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3899\/jrheum.100987","volume":"38","author":"S Masiero","year":"2011","unstructured":"Masiero\u00a0S et\u00a0al (2011) Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a\u00a0randomized controlled trial. J\u00a0Rheumatol 38(7):1335\u20131342","journal-title":"J Rheumatol"},{"issue":"5","key":"670_CR577","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.10658","volume":"47","author":"A Van Tubergen","year":"2002","unstructured":"Van Tubergen\u00a0A et al (2002) Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a\u00a0randomized controlled trial. Arthritis Rheum 47(5):459\u2013467","journal-title":"Arthritis Rheum"},{"issue":"7","key":"670_CR578","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s00393-008-0318-1","volume":"67","author":"W Mau","year":"2008","unstructured":"Mau\u00a0W, Muller\u00a0A (2008) Rehabilitation and outpatient physiotherapy in rheumatic disease patients. Results of cross-sectional studies of patients with rheumatoid arthritis or ankylosing spondylitis and rheumatologists. Z\u00a0Rheumatol 67(7):542\u2013553","journal-title":"Z Rheumatol"},{"issue":"1","key":"670_CR579","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/ard.2008.104117","volume":"69","author":"A Boonen","year":"2010","unstructured":"Boonen\u00a0A et\u00a0al (2010) ASAS\/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis 69(1):102\u2013107","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"670_CR580","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/rheumatology\/kep150","volume":"48","author":"A Boonen","year":"2009","unstructured":"Boonen\u00a0A et\u00a0al (2009) Aspects relevant for functioning in patients with ankylosing spondylitis according to the health professionals: a\u00a0Delphi study with the ICF as reference. Rheumatol (oxford) 48(8):997\u20131002","journal-title":"Rheumatol (oxford)"},{"issue":"12","key":"670_CR581","first-page":"2475","volume":"33","author":"I van Echteld","year":"2006","unstructured":"van Echteld\u00a0I et\u00a0al (2006) Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health. J\u00a0Rheumatol 33(12):2475\u20132483","journal-title":"J Rheumatol"},{"issue":"4","key":"670_CR582","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/1529-0131(199908)12:4<247::AID-ART3>3.0.CO;2-H","volume":"12","author":"MM Ward","year":"1999","unstructured":"Ward\u00a0MM (1999) Health-related quality of life in ankylosing spondylitis: a\u00a0survey of 175 patients. Arthritis Care Res 12(4):247\u2013255","journal-title":"Arthritis Care Res"},{"issue":"11","key":"670_CR583","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3899\/jrheum.090156","volume":"36","author":"A Boonen","year":"2009","unstructured":"Boonen\u00a0A et\u00a0al (2009) Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews. J\u00a0Rheumatol 36(11):2501\u20132511","journal-title":"J Rheumatol"},{"issue":"11","key":"670_CR584","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1136\/ard.2004.027185","volume":"64","author":"T Sigl","year":"2005","unstructured":"Sigl\u00a0T et\u00a0al (2005) ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis. Ann Rheum Dis 64(11):1576\u20131581","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"670_CR585","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/ard.2008.100164","volume":"69","author":"VS Gordeev","year":"2010","unstructured":"Gordeev\u00a0VS et al (2010) Role of contextual factors in health-related quality of life in ankylosing spondylitis. Ann Rheum Dis 69(1):108\u2013112","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"670_CR586","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/acr.22907","volume":"68","author":"S van Genderen","year":"2016","unstructured":"van Genderen\u00a0S et al (2016) Social role participation in patients with Ankylosing Spondylitis: a cross-sectional comparison with population controls. Arthritis Care Res (hoboken) 68(12):1899\u20131905","journal-title":"Arthritis Care Res (hoboken)"},{"issue":"2","key":"670_CR587","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s001080050745","volume":"42","author":"A Zink","year":"2001","unstructured":"Zink\u00a0A, Mau\u00a0W, Schneider\u00a0M (2001) Epidemiologische und sozialmedizinische Aspekte entz\u00fcndlich-rheumatischer Systemerkrankungen. Internist (Berl) 42(2):211\u2013222","journal-title":"Internist (Berl)"},{"issue":"2","key":"670_CR588","first-page":"315","volume":"28","author":"MM Ward","year":"2001","unstructured":"Ward\u00a0MM, Kuzis\u00a0S (2001) Risk factors for work disability in patients with ankylosing spondylitis. J\u00a0Rheumatol 28(2):315\u2013321","journal-title":"J Rheumatol"},{"issue":"11","key":"670_CR589","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10067-009-1249-1","volume":"28","author":"E Cakar","year":"2009","unstructured":"Cakar\u00a0E et al (2009) Work disability in ankylosing spondylitis: differences among working and work-disabled patients. Clin Rheumatol 28(11):1309\u20131314","journal-title":"Clin Rheumatol"},{"issue":"5","key":"670_CR590","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/ard.61.5.429","volume":"61","author":"A Boonen","year":"2002","unstructured":"Boonen\u00a0A et\u00a0al (2002) Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61(5):429\u2013437","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR591","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/ard.60.4.353","volume":"60","author":"A Boonen","year":"2001","unstructured":"Boonen\u00a0A et\u00a0al (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a\u00a0cross sectional study of Dutch patients. Ann Rheum Dis 60(4):353\u2013358","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR592","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/acr.22730","volume":"68","author":"JD Castillo-Ortiz","year":"2016","unstructured":"Castillo-Ortiz\u00a0JD et al (2016) Work outcome in patients with Ankylosing Spondylitis: results from a\u00a012-year followup of an international study. Arthritis Care Res (hoboken) 68(4):544\u2013552","journal-title":"Arthritis Care Res (hoboken)"},{"key":"670_CR593","first-page":"51","volume-title":"Pr\u00e4diktion, Verfahrensoptimierung und Kosten in der medizinischen Rehabilitation","author":"A B\u00f6nisch","year":"2005","unstructured":"B\u00f6nisch\u00a0A et al (2005) Evaluation eines Schulungsprogramms f\u00fcr Patienten mit Spondylitis ankylosans. In: Pertermann\u00a0F (Hrsg) Pr\u00e4diktion, Verfahrensoptimierung und Kosten in der medizinischen Rehabilitation. S\u00a0Roderer, Regensburg, S\u00a051\u2013102"},{"key":"670_CR594","first-page":"103","volume-title":"Pr\u00e4diktion, Verfahrensoptimierung und Kosten in der medizinischen Rehabilitation","author":"C Krauth","year":"2005","unstructured":"Krauth\u00a0C et al (2005) Gesundheits\u00f6konomische Evaluation eines Patientenschulungsprogramms Spondylitis ankylosans in der station\u00e4ren Rehabilitation. In: Petermann\u00a0F (Hrsg) Pr\u00e4diktion, Verfahrensoptimierung und Kosten in der medizinischen Rehabilitation. S\u00a0Roderer, Regensburg, S\u00a0103\u2013143"},{"issue":"1","key":"670_CR595","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1055\/s-0032-1305165","volume":"52","author":"W Mau","year":"2013","unstructured":"Mau\u00a0W, Ehlebracht-Konig\u00a0I (2013) Rehabilitation in axial spondyloarthritides. Rehabilitation (Stuttg) 52(1):51\u201362","journal-title":"Rehabilitation (Stuttg)"},{"issue":"5","key":"670_CR596","first-page":"739","volume":"31","author":"C Rodriguez-Lozano","year":"2013","unstructured":"Rodriguez-Lozano\u00a0C et al (2013) Outcome of an education and home-based exercise programme for patients with ankylosing spondylitis: a\u00a0nationwide randomized study. Clin Exp Rheumatol 31(5):739\u2013748","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"670_CR597","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3899\/jrheum.110641","volume":"38","author":"DL Mattey","year":"2011","unstructured":"Mattey\u00a0DL et al (2011) Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis. J\u00a0Rheumatol 38(12):2608\u20132615","journal-title":"J Rheumatol"},{"issue":"2","key":"670_CR598","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00296-016-3590-4","volume":"37","author":"S Zhao","year":"2017","unstructured":"Zhao\u00a0S et\u00a0al (2017) Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. Rheumatol Int 37(2):239\u2013244","journal-title":"Rheumatol Int"},{"issue":"7","key":"670_CR599","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/art.24585","volume":"61","author":"MM Ward","year":"2009","unstructured":"Ward\u00a0MM et\u00a0al (2009) Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 61(7):859\u2013866","journal-title":"Arthritis Rheum"},{"issue":"6","key":"670_CR600","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","volume":"78","author":"M Dougados","year":"2011","unstructured":"Dougados\u00a0M et al (2011) The DESIR cohort: a\u00a010-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 78(6):598\u2013603","journal-title":"Joint Bone Spine"},{"issue":"6","key":"670_CR601","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/annrheumdis-2011-200180","volume":"71","author":"HY Chung","year":"2012","unstructured":"Chung\u00a0HY et al (2012) Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis 71(6):809\u2013816","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"670_CR602","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/berh.2002.0242","volume":"16","author":"E Feldtkeller","year":"2002","unstructured":"Feldtkeller\u00a0E (2002) Do patient self-help organizations help? Best Pract Res Clin Rheumatol 16(4):667\u2013673","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-019-0670-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-0670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T18:17:39Z","timestamp":1722104259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-019-0670-3"}},"subtitle":["Evidenzbasierte Leitlinie der Deutschen Gesellschaft f\u00fcr Rheumatologie (DGRh) und der beteiligten medizinisch-wissenschaftlichen Fachgesellschaften und weiterer Organisationen*","Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations"],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":602,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s00393-019-0670-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"29 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Angaben zum Interessenkonflikt aller Leitlinienautoren sind im Leitlinienreport unter\n                      \n                      einsehbar.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}